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INTRODUCTION 
 
All organisms rely on electron transport to facilitate molecular transformations and 
for fundamental processes essential for life. Proteins involved in reduction-oxidation 
(redox) reactions generally contain redox active cofactors such as metal ions, hemes, 
flavins, disulfides, iron-sulfur (Fe-S) clusters or NADPH, which are all used in electron 
transfer reactions. Combined biochemical and biophysical approaches are important and 
widely used to understand these fascinating mechanisms.  
Metal ions and redox chemistry in biology  
The importance of inorganic compounds and metal ions in biological processes is 
indisputable. Metal ions play a central role in many challenging chemical reactions and in 
energy metabolism (1). It is estimated that 30-50% of all proteins require the presence of 
metal ions for their biological activity (2). Metalloproteins utilize metal ions as structural 
features, for fast information transfer, participation in catalysis by orienting substrates for 
reactions, functioning as Lewis acids in formation, degradation and metabolism of organic 
compounds, in signaling pathways, and in redox reactions (3). Several important 
biocatalytic processes, such as nitrogen fixation, methane biogenesis and oxidation, 
oxygen storage, and formation, utilization and degradation of metabolites, involve the 
presence of metalloenzymes. Many proteins coordinate the metal ions directly through 
charged or polar side chains, while others contain metals covalently incorporated in 
prosthetic groups, such as the protoporphyrins in heme proteins, and Fe-S clusters in Fe-S 
proteins. The metal ions included in the protein scaffold are cations characterized by 
different oxidation states, as well as experiencing different coordination environments. 
Transition metals, such as iron, manganese and copper are often found in the active site of 
enzymes that activate or transport oxygen (4). Molecular oxygen plays a key role in many 
important biological processes. The ground state of molecular oxygen is the relatively 
unreactive triplet state (S=1) with two unpaired electrons. This makes spontaneous 
reactions between carbon compounds and molecular oxygen kinetically slow. To overcome 
this restriction, many proteins make use of transition metal ions, radicals, or organic 
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cofactors to activate oxygen. Transition metals, for example, are not limited to one spin 
state, and may accept or donate electrons involved in the reaction, enabling enzymes to 
catalyze their reaction by converting oxygen to reactive states, through rearrangement of 
electrons in the partially filled transition metal ions d-orbitals (5,6). As an example, some 
classes of ribonucleotide reductase (RNR) proteins use their metallocofactor to activate 
oxygen and generate a stable radical on a nearby tyrosine residue.    
 Iron is one of the most abundant and versatile metals found in proteins, and it is 
present throughout most living systems. It may be assembled into heme proteins, iron-
sulfur clusters or non-heme mono -or dinuclear cofactors. In heme proteins, iron functions 
in storage and transport of oxygen, as in myoglobin and hemoglobin, respectively; in 
cytochromes as electron carriers (7); in heme-containing dioxygenases, involved in 
tryptophan regulation (8); in heme monooxygenases, incorporating a hydroxyl group into 
substrates, or in heme peroxidases, where the heme group participates in the oxidation of 
different substrates, e.g. cytochrome c peroxidase where also a Trp radical is generated (9). 
Additionally, iron is an important detoxifying agent in catalase and superoxide dismutase. 
Non-heme diiron carboxylate/iron-oxygen proteins catalyze a wide range of redox 
reactions (10,11). Some members of this family of proteins are the radical-forming R2 
subunits of ribonucleotide reductases (RNRs) (see below) (12), methane monooxygenase 
hydroxylase (13), and iron storage proteins, such as ferritins (14).    
 Iron has the ability to exist in several oxidation states, mainly FeII (ferrous iron) and 
FeIII (ferric iron) in biology, but also as FeIV=O (ferryl). In reactions catalyzed by iron-
containing enzymes, iron normally undergoes changes in oxidation state during the 
catalytic cycle (15). Another important transition metal able to reach the same oxidation 
states as iron, manganese, is also used by several metalloenzymes, such as the oxygen-
evolving complex in photosystem II (16). The ability to incorporate different 
metallocofactors has also been shown to be widespread in some enzymes, such as in two 
RNR subclasses (Figure 1), where one subclass can utilize either a dinuclear iron -or 
manganese cofactor (17,18), while another subclass has been found to use a 
heterodinuclear iron-manganese cofactor (19,20).    
 Metalloprotein redox chemistry is crucial in a wide variety of enzymes throughout 
nature. However, electron transfer through redox centers that do not contain metal ions is 
also an important part of redox transitions in cells. These redox centers can also be linked 
to metallocofactors in redox networks. This includes organic coenzymes such as flavin -
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and nicotinamide coenzymes, tetrahydrobiopterins, chlorophylls, vitamin B12 coenzymes, 
S-adenosyl methionine (AdoMet or SAM), as well as thiol-disulfide exchanging enzymes, 
which all play crucial roles in various redox reactions (21).    
 The cofactor of flavoproteins is derived from riboflavin, consisting of an 
isoalloxazine ring system serving in reversible electron transfer. Flavoproteins are capable 
of both one -and two-electron transfer processes, catalyzing a versatility of reactions, such 
as reduction of hydroperoxides, hydroxylation of aromatic compounds, participation in 
light-initiated reactions as well as in programmed cell death (22). While some protein-
bound flavins serve as unspecific electron donors in several redox pathways, certain 
flavoproteins participate in distinct pathways, such as the flavin mononucleotide cofactor 
(FMN) containing flavodoxin NrdI, which has been suggested to serve as a specific 
electron donor for the class Ib RNR small subunit (23). The large Complex I of the 
electron-transport chain in the inner mitochondrial membrane is an example of a system 
utilizing several redox centers. Complex I passes electrons in a multistep path from the 
nicotinamide coenzyme NADH to ubiquinone, through a FMN cofactor and a series of Fe-
S clusters (21,24). Thioredoxin reductase (TrxR) in another example of a system 
containing multiple redox centers. This dimeric flavoenzyme containing a flavin adenine 
dinucleotide (FAD) cofactor catalyzes the NADPH-dependent reduction of thioredoxins 
(Trxs) through a reversible thiol-disulfide exchange reaction (25). Trx-like proteins are 
required as hydrogen atom donors for the active site in the catalytic subunit of RNR 
(26,27).  
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Ribonucleotide reductase 
Even though RNRs have been studied elaborately and extensively for many 
decades, more detailed electronic and structural knowledge regarding the metal binding 
site is still needed. A deeper understanding of the structures and interaction pathways 
among the different proteins involved in the RNR system would also provide important 
functional insight in the nature of this fascinating enzyme.     
 The reduction of ribonucleotides to deoxyribonucleotides was first suggested by 
Jean Brachet in 1933 (28). However, the first evidence for this reaction performed through 
isotope experiments, emerged almost 20 years later by Peter Reichard and co-workers (29). 
These findings led Reichard to the initial discovery of RNR (30,31), and opened an 
exciting and fascinating field of research (32) for molecular biologists, biochemists and 
biophysicists, which has now lasted for more than 50 years.    
 RNRs catalyze the reduction of ribonucleotides to their corresponding 
deoxynucleoside 5’–di– or triphosphates (dNDPs or dNTPs) (33,34) (Scheme 1).  
 
 
 
Scheme 1. The reduction of ribonucleotides to their corresponding deoxyribonucleotides by RNR. 
 
This enzyme plays an important role in nucleotide metabolism, being responsible for the de
novo synthesis of all four DNA precursors, hence being crucial in all DNA-based living 
organisms. The proposed reaction of ribonucleotide reduction, explained with a reaction 
mechanism involving an active site thiyl radical (S•) being responsible for hydrogen 
abstraction (35), where one carbon bound hydroxyl group of ribose could be directly 
replaced by a hydrogen atom, was first discovered in RNR. All RNRs share a common 
catalytic mechanism involving the activation of a ribonucleotide by abstraction of the 3’-
hydrogen atom of ribose by a transient S• in the catalytic subunit, leading to the exchange 
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of the hydroxyl group on the 2’-carbon of the ribose ring with a hydrogen atom (36). RNRs 
are divided into three main classes, differing in how they generate the S•, and are discussed 
in more detail below. An overview of the current perception of all RNR classes, including 
substrates, radical initiators, and in vivo reductants is shown in Figure 1. The RNR system 
involves a fascinating variety of interacting proteins and redox cofactors, such as non-
heme diiron proteins, thiol-disulfide oxidoreductases, flavoproteins, NADPH-dependent 
proteins, AdoMet, a vitamin B12 cofactor and a 4Fe-4S cluster. Due to their importance in 
proliferating cells, RNRs are potential drug targets for cancer treatment, for antiviral agents 
and for novel antibiotics in the fight against pathogenic bacteria.   
Classification of RNRs 
All RNRs are believed to have the same evolutionary origin, with a similar S• based 
reaction mechanism and a conserved ten-stranded D/E barrel fold of the catalytic subunit 
enclosing the S• (Figure 2) (37,38). However, the RNRs have been divided into three 
different classes based on allosteric regulation, oxygen dependency, sequence similarity 
and the cofactor utilized to generate the S• (12,39,40).     
 Class I RNRs are oxygen-dependent RNRs, generating a stable tyrosyl radical (Y•) 
(classes Ia and Ib) using a dinuclear metal cofactor in a small, radical-generating subunit, 
from where the Y• is shuttled to the catalytic subunit for every turnover. Class Ia RNR is 
the only class encoded in eukaryotes, but exists also in bacteria and viruses. Consisting of 
only one subunit, the prokaryotic class II RNRs (encoded by the nrdJ or nrdZ genes) 
generate their radical from the homolytic cleavage of the carbon-cobalt bond in the vitamin 
B12 cofactor (adenosylcobalamin) (41). In this reaction, CoIII is reduced to CoII, and a 
deoxyadenosyl radical is formed. The cofactor binds in the D/E barrel fold close to the 
substrate binding site and the cysteine that is oxidized to S• (42). Both of these classes 
operate in the presence of oxygen, class I being strictly aerobic, whereas class II having 
two independent pathways for radical generation, one being oxygen-dependent (41). Class 
III RNRs (belonging to the radical SAM superfamily) (encoded by the nrdD-nrdG genes) 
are anaerobic and use a 4Fe-4S cluster to homolytically cleave AdoMet, generating a 
glycyl radical via a deoxyadenosyl radical, in the separate cluster containing activase. This 
glycyl radical, which is very sensitive to oxygen, is responsible for S• generation in the 
active site (34,43).  
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Figure 1. Schematic overview of the three RNR classes, showing the diversity of substrate 
specificity, electron donors and radical initiators. The figure is adapted from (44) and (45), with 
some modifications. 
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Figure 2. Crystal structures of the catalytic subunits in different RNR classes, showing the 
conserved D/E barrel fold. The active site cysteine responsible for S• generation is shown in the 
center of the barrel in yellow ball-and stick representation. (A) Human class I NrdA 
(PDBid:2WGH) (46), (B) Lactobacillus leichmannii class II NrdJ (PDBid:1L1L) (37), and (C) 
bacteriophage T4 class III NrdD (PDBid:1H7A) (47). 
 
Class I RNRs 
All class I RNRs contain two components; one catalytic subunit where the substrate 
binding site is located (R1), and one component responsible for generation of a radical 
center (R2). Active class I RNRs are assembled as two homodimeric subunits, D2 and E2.  
Nucleotide reduction is initiated through the reversible one electron oxidation of a 
conserved cysteine residue to a S• in the larger catalytic D2 subunit (R1), originated by a 
dinuclear metallocofactor and Y• positioned in the E2 subunit (R2) (classes Ia and Ib).  
The R2 subunit has a conserved structural fold consisting of an eight-helical bundle, as 
initially reported in the first structure of the radical-generating subunit from Escherichia
coli in 1990 (48,49). All R2 subunits contain a dinuclear metal cluster located within a 
four-helix bundle (50), and the metal-binding residues are identical in most class I RNRs, 
where the di-metal clusters are coordinated by four carboxylates and two histidines, in 
close proximity to the tyrosine residue that generates the Y• (51) (or a phenylalanine in 
class Ic) (Figures 3 and 4).  
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Figure 3. The RNR class Ia R2 subunit from E. coli (PDBid:1RIB) (49). The two monomers of the 
radical-generating subunit are colored by monomer and displayed as a dimer (E2) (left). The 
monomers each contain two iron ions, shown as orange spheres. The inset panel on the right shows 
the metal ion site, where the Fe ions are shown as orange spheres, and the coordinating amino acids 
and Tyr are represented as sticks and colored by atom type.   
 
The class I RNRs are divided into three structurally homologous subclasses; Ia, Ib, 
and Ic (Figure 4). Although class Ia and Ib RNRs have identical coordination sites, studies 
have shown that the class Ib NrdF can also utilize an active MnIII2-Y• cofactor (Figure 4D) 
(17,18,52), in addition to the classical FeIII2-Y• cofactor (Figures 4A-C), which can be 
assembled in both subclasses (53,54). In contrast to classes Ia and Ib, the newly discovered 
class Ic RNR, so far only characterized in the intracellular pathogen Chlamydia 
trachomatis, has been shown to be able to utilize a stable, heterodinuclear MnIVFeIII 
cofactor (Figures 4E and F) to initiate reduction of nucleotides in the catalytic site of R1 
(19,20,55,56). This subclass contains a phenylalanine residue instead of the radical-
generating tyrosine found in classes Ia and Ib. The different RNR subunits are encoded by 
the nrd genes. The NrdA/NrdE (R1/R1E) and NrdB/NrdF (R2/R2F) subunits are encoded 
by the nrdA and nrdB genes, respectively, in class Ia; the nrdE and nrdF genes, 
respectively, in class Ib; and by the nrdA and nrdBPhe genes, respectively, in class Ic. While 
the operon structures of the genes encoding these subunits are nrdAB and nrdABPhe in 
classes Ia and Ic, respectively, the class Ib RNR operon structure encodes two additional 
proteins; NrdH and NrdI, and the gene arrangement is in most cases nrdHIEF. Class Ib 
RNRs will be discussed in more detail in the next section.  
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Figure 4. The metal ion sites in class Ia, Ib and Ic RNR. Fe -and Mn ions are shown as orange and 
purple spheres, respectively, and the coordinating amino acids and Tyr or Phe are represented as 
sticks and colored by atom type. (A) E. coli class Ia RNR (PDBid:1MXR) (57), (B) mouse class Ia 
RNR (PDBid:1W68) (50), (C) Salmonella typhimurium class Ib RNR (PDBid:2R2F) (58), (D) C. 
ammoniagenes class Ib RNR (PDBid:3MJO) (17), (E) C. trachomatis class Ic RNR (PDBid:1SYY) 
(55), and (F) C. trachomatis class Ic RNR (coordinates were obtained from Martin Högbom) with 
one metal center occupied by iron and the other by manganese. 
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Many organisms can express multiple classes of RNRs, where expression varies 
depending on growth conditions, such as adaptation to different O2 levels in the 
environment. Further complexity can also be provided by the presence of more than one 
enzyme belonging to the same class or subclass. For example, Streptomyces clavuligerus 
and Pseudomonas aeruginosa express class I and class II RNRs, using both classes during 
aerobic growth (59,60). E. coli expresses two subclasses of class I RNRs; class Ia and class 
Ib (61) (in addition to class III (62)) while Saccharomyces cerevisiae contains two 
essential RNR small subunit genes, as well as two large subunit genes, coding for four 
proteins with non-overlapping function (63-65). Another example is the presence of a p53-
incucible small subunit found in mammals, fishes, birds and possibly nematodes. The 
p53R2 protein is expressed when the tumor suppressor protein p53 is defective (66,67). 
Mycobacterium tuberculosis encodes the class Ib RNR as well as the class II RNR. The 
class Ib RNR in M. tuberculosis, however, is coded by a gene cluster containing intergenic 
spacings, contrary to the nrdHIEF operon structure seen in most class Ib RNR containing 
genomes (Figure 5). The well-characterized M. tuberculosis active small subunit, 
NrdF2/R2F-2, is encoded by the nrdF2 gene. In addition, an alternate small subunit, 
NrdF1/R2F-1, encoded by nrdF1 is expressed in this bacterium, previously thought to be 
unable to form a functional class Ib RNR with R1 (68-71) (see Paper I). Recently, another 
R2c-like protein (Rv2033) was characterized in M. tuberculosis, denoted R2lox, lacking 
RNR activity, and proposed to be a ligand oxidase (72). 
 
 
 
Figure 5. Organization of the RNR-encoding genes in M. tuberculosis, shown as arrows. The 
nrdF1 gene is not linked to nrdF2, and neither of the genes encoding the small subunit of class Ib 
RNR are linked to nrdE; the gene encoding the large subunit.  
 
All class I RNR subclasses are usually assembled in the D2E2 functional form 
(Figure 6A). However, different oligomeric forms have recently been described and 
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discussed (Figure 6) (46,73-76). Recent human R1 structures show binding of effectors at 
different recognition-binding sites in an D2 assembly (Figure 6B), and an inactive D4E4 
oligomeric form of the E. coli class Ia RNR has been observed in the presence of elevated 
levels of dATP (Figure 6D), also obtained as an interlock form of an (D4E4)2 complex (77). 
Additionally, a hexameric D6 ring-like structure has been observed in the crystal packing of 
R1 from S. cerevisiae (Figure 6C).  
 
 
 
Figure 6. Different RNR molecular assemblies. (A) The proposed E. coli class Ia D2E2 complex, 
generated by alignment of the R2 dimer (E2) with the R1 dimer (D2), using the original class Ia D2E2 
holocomplex coordinates (PDBid:1RIB) (49,78), (B) the human R1 dimeric structure (D2) shown 
with TTP (green), GDP (red) and ATP (orange) bound at the S (specificity) site, C (catalytic) site 
and A (activity) site, respectively (PDBid:3HND, 3HNE) (46), (C) hexameric packing of R1 (D6) in 
S. cerevisiae (PDBid:3PAW) (46), (D) the D4E4 ring-like structure in E. coli (PDBid:3UUS) (75), 
see also (76).   
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The class Ib RNR system 
Class Ib RNRs are the primary sources of dNTPs for a wide variety of prokaryotes, 
including many pathogens, such as M. tuberculosis, Bacillus anthracis, Streptococcus 
pyogenes, and Bacillus cereus (79). The class Ib enzyme consists of the D2 (NrdE) and E2 
(NrdF) subunits (58), where the active form, as in class Ia, is believed to comprise an D2E2 
stoichiometry (38,78). Initially, class Ia and Ib RNRs were divided into two subclasses 
based on polypeptide sequence homology and allosteric regulation. Both subclasses 
possess identical metal-binding residues, and they were for a long time assumed to 
generate an FeIII2-Y• cofactor. However, initially proposed by Auling and coworkers (80-
82), several recent studies performed on class Ib RNRs from E. coli (18,83), 
Corynebacterium ammoniagenes (17), Bacillus subtilis (84-86), B. anthracis (87), and B. 
cereus (52,87) have demonstrated that these RNRs can also utilize a MnIII2-Y• cofactor in 
their NrdF subunits, to initiate nucleotide reduction in R1. Hence, class Ib RNRs are 
unique in that they can assemble both active FeIII2-Y• and MnIII2-Y• cofactors.  
Active FeIII2-Y• cofactor generation 
Similar to the class Ia RNR, the FeIII2-Y• cofactor can be formed in vitro by self-
assembly from apo-NrdF in the presence of FeII, O2, and an additional electron, forming 
the Y• required for dNDP formation in the D2 subunit (NrdE) (39,53,54,88). The formation 
of the FeIII2-Y• has been well characterized in the class Ia RNRs, and has been studied in 
detail especially in E. coli. The diferric iron cluster and the Y• are formed when molecular 
oxygen reacts with diferrous iron in the radical generating RNR subunit:  
Y + FeIIFeII + O2 + H+ + e- Æ Y• + FeIII-O-2-FeIII + H2O 
After oxygen binding to the diferrous iron site, a μ-peroxodiferric intermediate (FeIII-O-O-
FeIII) is likely formed (89,90), possibly followed by reduction by a neighboring tryptophan 
residue, leading to the formation of intermediate X (FeIV-O-FeIII) (91,92). This 
intermediate spontaneously decays to the active FeIII-O-FeIII cluster, oxidizing the nearby 
catalytically essential tyrosine to a Y•. Kolberg et al. (36) have proposed a reaction 
pathway for the generation of the Y• in E. coli class Ia R2, which was recently also revised 
by Tomter et al. (45). 
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Active MnIII2-Y• cofactor generation 
Contrary to the self-assembly of the active FeIII2-Y• cofactor in NrdF, the active 
MnIII2-Y• cofactor can only be generated from the MnII2 site in a self-assembly process in 
the presence of O2  and the reduced flavodoxin-like protein NrdI (18). NrdI, encoded by the 
nrdI gene, is found in all organisms with genomes coding for the class Ib RNR (93,94). In 
most organisms expressing the class Ib RNR, the corresponding genes are organized in a 
cotranscribed nrdHIEF operon structure (61). NrdI contains an FMN cofactor, 
demonstrated to be able to act as a two-electron reductant (95,96) (Figure 7), and originally 
proposed to act as a reductant for generation and maintenance of the active FeIII2-Y• 
cofactor (93). However, later biochemical studies proposed that NrdI, in its fully reduced 
hydroquinone form (NrdIhq, containing FMNH-) reacts with O2 providing the oxidant, H2O2 
or HO2-, required for generation of the active MnIII2-Y• cofactor, also supported by 
spectroscopic and crystallographic studies (17,18,97). The most recent work in this field, 
elucidated by Cotruvo et al. (23), has suggested through monitoring of the MnIII2-Y• 
cofactor assembly by stopped flow absorption and rapid freeze quench EPR 
spectroscopies, that the metal-ion cluster oxidant is in fact O2Ɣ- (Figure 8). This reactive 
oxygen species is produced by the reaction of NrdIhq with O2, oxidizing NrdI to its neutral 
semiquinone form (NrdIsq, containing FMNH•) (23). The hydrophilic O2Ɣ- is believed to 
diffuse through a proposed hydrophilic solvent channel, extending from the flavin cofactor 
of NrdI to metal site 2 in NrdF. This channel is structurally conserved in B. cereus and E.
coli NrdF, as confirmed by the two first crystal structures of NrdI in complex with NrdF 
(97) (see Paper II). This oxidant channel is distinct from the hydrophobic access route 
proposed for O2  transport to the diferrous site in class Ia RNR, and presumably also for 
class Ib FeII2-containing RNRs (49). Studies have shown that the MnIII2-Y• cofactor can be 
formed both in vitro and in vivo (52,83), and that the manganese form of the enzyme has a 
higher specific activity compared to the iron form, as in the case of B. anthracis (87), B.
cereus (98) and B. subtilis (84), all showing a 10-fold increase. It is still not fully 
understood how the in vitro process of cofactor assembly using identical metal 
coordinating ligands, but different metals and oxidants (99), is controlled in vivo.
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Figure 7. (A) Overall structure of the B. cereus NrdI (PDBid:2X2O) (96), with the FMN cofactor 
represented as sticks. (B) Structural alignment of NrdI structures with the FMN cofactor in 
different redox states. Residues proximal to the FMN cofactor on the 40S loop, as well as the active 
site of the oxidized form of the FMN cofactor are shown in yellow (PDBid:2X2O), while the one-
electron reduced semiquinone form is shown in turquoise (PDBid:2X2P) (96), all shown as sticks. 
A conformational change in the 40S loop is induced upon reduction of the FMN cofactor, resulting 
in a peptide flip between residues 44 and 45. This orients the Gly44 carbonyl group towards N5 of 
the FMN cofactor, initiating hydrogen bonding (shown as dashed lines). (C) Flavin mononucleotide 
redox and protonation states. 
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Figure 8. The latest proposed mechanism of MnIII2-Y• generation in NrdF. One-electron reduction 
of O2 by NrdIhq generates O2Ɣ-.The O2Ɣ- is proposed to be channeled through a hydrophilic solvent 
channel to MnII2-NrdF, reacting with and forming a MnIIIMnIV intermediate, which decays to 
MnIIIMnIII, oxidizing tyrosine to Y•. The detailed structures of the proposed MnIIMnIII-OO(H) and 
MnIIIMnIV intermediates are unknown (23), where the latter intermediate might also exist in a 
different resonance condition. The oxidation state of NrdI when it dissociates from NrdF is also 
unknown. Mn2 is indicated in red.  
 
In addition to the proteins encoded by the nrdHIEF operon, several accessory 
proteins have been shown or are suggested to act as interacting redox partners in the class 
Ib RNR. Ferredoxin/flavodoxin-NADP(H) oxidoreductases (FNRs) catalyse the reversible 
redox reaction between ferredoxins or flavodoxins and NAD(P)+/NAD(P)H. Some of these 
are believed to provide reducing power to NrdI, as well as to other ferredoxin/flavodoxin-
dependent enzyme systems such as some cytochrome P450s and methionine synthase 
(100-102). Reduction of the active site of the catalytic subunit of classes I RNRs is 
performed through the assistance of glutaredoxins (Grxs), Trxs, and other subclasses of the 
Trx superfamily. A detailed introduction to these disulfide oxidoreductases will be given in 
a later section.   
Radical transfer from R2 to R1  
RNRs use, as already mentioned, a free-radical mechanism, in which a transient S• 
in the active site of R1 initiates ribonucleotide reduction by abstraction of a hydrogen atom 
(H•) from the C3’ of the ribose ring. In class II and III RNRs, the active site cysteine is 
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oxidized by direct hydrogen abstraction by a 5’deoxyadenosyl radical or a stable glycyl 
radical, respectively. In the case of class I RNRs, oxidation occurs by the Y• (class Ia and 
Ib) or MnIVFeIII cluster (class Ic) stored in a subunit (R2) different than the catalytic R1 
subunit. In the case of class Ia RNR, in which the radical initiation process has been 
studied extensively (103-106), the distance between the Y• in R2 and the active site 
cysteine in R1 has been proposed to be ~35 Å, based on the 3D model of the R1-R2 
complex (78), as well as kinetic techniques and different spectroscopies, such as pulsed 
electron-electron double resonance (PELDOR) spectroscopy (107,108). Rather than a 
slow, single electron tunneling step, conserved redox-active aromatic amino acids in both 
subunits have been proposed to mediate a long-range intersubunit electron transfer with 
transient radical formation. The electron transfer is thought to be coupled to several short-
range proton transfer steps (proton-coupled electron transfer or PCET). Even though no 
structure of the functional D2E2 holoenzyme has been obtained till date, a radical transfer 
mechanism mediated by the aromatic residues has been established based on a docking 
model of R1-R2 (78). However, less is known about the proton transfer. Recent studies 
have also shown that the FeIII2 cluster in class Ia E. coli RNR also functions in the enzymes 
catalytic cycle, in addition to generation of the Y• (109).  
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Thioredoxin  
Thiol-redox diversity 
Redox pathways based on disulphide-bridges are involved in a variety of cellular 
processes, such as protein folding (110), enzymatic reactions as hydrogen donors (26), 
response to oxidative stress (111) and modulation of protein activity (112), and are 
important in the maintenance of redox states in cells. The involvement of thiols is also 
common for all RNR classes, where redox-active cysteines, thiyl radicals and thiol 
containing proteins play an essential role in the catalytic cycle of RNRs. In the oxygen-
dependent class I and II RNRs, a pair of cysteines performing the reduction of the substrate 
is located in the active site of R1, in addition to the cysteine forming the thiyl radical. The 
active site cysteine pair is oxidized during the reaction, and is reduced by two additional 
cysteines located on the flexible C-terminus of the R1 subunit. Consequently, these C-
terminal cysteines need to be reduced by an external reductant for each turnover (27,113). 
Such reduction reactions of disulfide bonds, as well as oxidation reactions of cysteine 
pairs, are mediated by thiol-disulfide oxidoreductases. The thiol-disulfide oxidoreductases 
are members of the Trx superfamily, performing the fast and reversible thiol-disulfide 
exchange between their active site cysteines and cysteines in the substrate protein (25). 
Trxs are small ubiquitous proteins found in bacteria, plants and animals. They all share a 
common C-X-X-C active site motif and show a conserved D/E/D sandwich polypeptide 
fold. Examples of E. coli proteins exhibiting different functions, but all having a Trx-like 
fold, are presented in Figure 9. In class III RNRs, only one of the two active site cysteines 
found in class I and II RNRs is conserved, while the other is entirely absent. In contrast to 
Trx-like proteins, the reductant of the class III RNRs is formate, which is oxidized to 
carbon dioxide during catalysis (114,115).      
 Proteins involved in the oxidation of disulfide bonds, such as DsbA (a member of 
the Dsb (disulfide bond) family of enzymes), are involved in disulfide bond formation in 
periplasmic proteins in bacteria, catalyzing the oxidation of peptide and protein cysteines 
(116). Also, eukaryotic protein disulfide isomerases (PDI) are involved in the 
rearrangement of incorrectly disulfide-bonded proteins in the lumen of the endoplasmic 
reticulum of eukaryotic cells (117,118). 
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Figure 9. E. coli proteins belonging to the Trx superfamily, all containing the Trx-like fold and the 
C-X-X-C active site motif. (A) TrxA (PDBid:2TRX) (119), (B) Grx (PDBid:1EGO) (120), (C) 
DsbA (PDBid:1FVK) (121), and (D) NrdH-redoxin (PDBid:1H75) (122). 
 
In the cytoplasm of E. coli, several pathways play roles in the reduction of disulfide 
bonds. Among the most studied members are the two thiol-disulfide bond reducing 
systems using the reducing potential derived from NADPH in the reduction of multiple 
cytoplasmic enzymes; the Trx system and the Grx system. The latter consists of three Grxs, 
glutathione (GSH) and glutathione reductase (Gor), while the former is composed of two 
Trxs and TrxR (25). The electrons from NADPH are transferred via TrxR or Gor, 
homodimeric enzymes called pyridine nucleotide disulfide oxidoreductases. TrxR reduces 
Trx, while Gor reduces glutathione disulfide (GSSG), a disulfide derived from two GSH 
molecules, to GSH, which then reduces Grx (123,124). In addition, NrdH-redoxin, which 
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functions as an electron donor for NrdE in the bacterial class Ib RNR, also has the Trx-like 
fold. This small redox protein, found in E. coli and several other organisms, is related in 
amino acid sequence to Grxs, but behave functionally as Trxs (122). While Grxs reduce 
their substrates using electrons derived from NADPH via Gor and GSH, Trxs and NrdHs 
reduce their substrates using electrons from NADPH via TrxR, as illustrated in Scheme 2. 
 
 
 
Scheme 2. The electron flow from NADPH to the final substrate, mediated by TrxR and Trx. 
 
Other members of the Trx superfamily, are the glutathione S-transferases and the 
hydroperoxidases (125), however, these proteins do not contain a C-X-X-C active site 
motif. Regardless of differences in their active sites, all the above mentioned proteins are 
related by their Trx fold, forming distinct, but structurally related families (126). 
The thioredoxin-like fold and active site motif 
The crystal structure involving an oxidized active site C-X-X-C motif was first 
solved for the E. coli Trx (127), in which the molecule showed to include a central E-sheet 
motif, and hence, core of five parallel and antiparallel strands surrounded by four D-
helices. Thus, the characteristic Trx-fold is noticeably smaller than Trx itself, lacking one 
E-strand and one D-helix. Extra residues and secondary structure elements are present in all 
other proteins containing the standard fold as well, in addition to the approximately 80 
residues making up the Trx fold. The four Grx orthologs found in E. coli also revealed the 
classical Trx-like fold with a central pleated sheet surrounded by helices (128,129). NrdH 
seems to be a hybrid of Trx and Grx (Figure 9). Despite these differences, functional 
similarity is found among several important classes of redox proteins, including Trx, NrdH 
and Grx, which all share the C-X-X-C similar reaction mechanisms.
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E. coli Trx1 was first discovered as the electron donor for RNR (26). Based on sequence 
similarity, a second Trx, Trx2, was also discovered as a reductant for RNR, despite some 
structural and functional differences compared to Trx1 (130). Grx1 was discovered as an 
alternative electron donor for RNR, coupling the reducing capacities of GSH and Gor to 
the enzymatic formation of deoxyribonucleotides (128,131,132). In addition to their 
involvement in electron transfer in several enzymatic systems, members of the Trx 
superfamily are involved in a range of other cellular functions, such as signal transduction 
pathways, sulfate assimilation and involvement in oxidative stress response (133-135). 
 The two cysteine residues in the C-X-X-C motif can reversibly form a disulfide 
bond, enabling Trx-related proteins to participate in disulfide exchange reactions (136). 
The residues between the two cysteines vary among the different protein classes, including 
Trxs and Grxs. In E. coli Trx, the disulfide bridge is formed from Cys32 and Cys35, 
spaced by Gly33 and Pro34 (C-G-P-C). Cys32 is the N-terminal nucleophilic cysteine, 
while Cys35 is the C-terminal, buried cysteines. The three Grx orthologs found in E. coli, 
Grx1, Grx2, Grx3 all share a C-P-[F-Y-W]-C active site sequence (137), whereas Grx4, a 
member of the last group of Grxs, is a monothiol enzyme containing an active site C-X-F-
X motif, usually as C-G-F-S (138,139). NrdH-redoxins typically contain a C-[VM]-Q-C 
motif (140). Other variations to the two residues flanking the redox active cysteines are 
found among additional members belonging to the Trx superfamily. DsbA contains an 
active site conserved C-P-H-C motif (141), while the eukaryotic PDI contains the active 
site sequence C-G-H-C (142). 
Mechanism of electron transfer in thioredoxin 
The reduction potentials of thiol-disulfide reactions are correlated with the pKa 
value of the surface exposed N-terminal reactive cysteines. A low redox potential has been 
correlated with a relatively high pKa value and vice versa. For example, the E. coli Trx low 
redox potential of -270 mV (143) is correlated with a relatively high pKa value of 7.1-7.4 
(144). Experiments have shown that the -X-X- residues in the active site motif contribute 
to changes in the pKa values, and hence, the tuning of redox potentials (145).  
 The side chain of the E. coli Trx N-terminal Cys32 is exposed to the solvent, and 
has a pKa value which is lowered from approximately 9 to 7, crucial to drive efficient thiol-
disulfide exchange reactions at physiological pH values (123). In order to give disulfide 
reductants low reduction potentials, nature has evolved enzymatic systems with the Cys32 
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thiol initiating the nucleophilic attack positioned in a special microenvironment. The 
lowered nucleophilic cysteine pKa value, leading to deprotonation, has been suggested to 
involve contributions from several factors, including assistance from an alpha-helix dipole 
(146), charge-charge interactions (147) and intra-protein hydrogen bonding (148). It has 
been proposed that the latter is the leading determinant to be considered when predicting 
pKa values, resulting in the suggestion that the low pKa value of the N-terminal Cys32 is 
due to hydrogen bonding to the Cys35 amide proton (149,150). However, the pKa value of 
Cys35 is estimated to values up to 4 units higher, making this residue virtually unreactive 
(136,151). There are no polar or acidic groups in the immediate environment of the C-
terminal buried Cys35 SJ-atom that can stabilize a thiolate prior to the second nucleophilic 
attack. As an explanation, a proximal, conserved Asp26 has been proposed to act as a 
general acid/base catalyst in the deprotonation of the thiol of Cys35, through a water 
molecule positioned between the Asp26 carboxyl group and the Cys35 SJ-atom (136,152). 
This hypothesis has later been supported by the analysis of a 1 Å resolution structure of 
oxidized Trx from Acetobacter aceti, where a water molecule is aligned between Asp26 
and Cys35, well positioned to participate in proton transfer between the Asp26 and Cys35 
side chains (153). However, reduced crystal structures of Trx showing this feature are yet 
not solved. Even though the replacement of Asp26 in Trx strongly impairs the catalytic 
reaction rate in the redox reactions of Trxs (154), the deprotonation mechanism of the 
buried Cys35 is still debated (136).        
 The fundamental mechanism of Trx-mediated electron transfer, proposed by Kallis 
and Holmgren in 1980 (155), is explained using E. coli amino acid numbering in Figure 
10. Electrons pass from reduced Trx to the substrate via several steps. The initial 
nucleophilic attack on the disulfide substrate involves Cys32, with the formation of a 
mixed disulfide (step 1) (Figures 10A and B). The next step, involving deprotonation of 
Cys35, makes the second nucleophilic attack caused by this thiolate possible. This resolves 
the mixed disulfide intermediate, generating a dithiol in the substrate (Figures 10C and D). 
The proton abstraction necessary to induce the nucleophilic attack of the last thiolate, 
illustrated in step 2, is possibly assisted by Asp26, but not completely understood.  
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Figure 10. The disulfide reductase reaction mechanism of Trx. (A) The initial nucleophilic attack 
performed by the Trx N-terminal Cys on the substrate disulfide bond is followed by a 
deprotonation of the buried C-terminal Cys (step 2) and a second nucleophilic attack, resolving the 
mixed disulfide intermediate (C), and leading to a reduced substrate (step 3 and D). 
 
Interestingly, variations to the possible role of Asp26 as an acid/base catalyst for 
the buried Cys are likely present among other subclasses of the Trx superfamily (Paper 
III). Some members lack the amino acid residue analogous to the E. coli and A. aceti Trx 
Asp26.  Examples of such groups of proteins, possessing Trx functionality, are the NrdH-
redoxins, previously shown to be able to act as reductants of the catalytic site of the R1 
subunit in the class Ib RNR (87,156,157), and Clostridium pasteurianum Cp9-redoxins, 
involved in the reduction of various hydroperoxide substrates (158).  
 
 
 
Figure 11. Organization of the genes encoding the B. cereus class Ib RNR. Contrary to the 
classical class Ib RNR operon structure, the gene coding for the putative NrdH-redoxin (BC3987) 
is not linked to the genes coding for NrdI, NrdE and NrdF. 
 
The class Ib RNR operon from B. cereus lacks the nrdH gene encoding the NrdH-
redoxin, differing from other characterized class Ib RNRs. However, a gene coding for a 
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small Trx-like protein, BC3987 (Figure 11), has been located in the B. cereus genome, 
revealing a significant amino acid sequence similarity with NrdH. The mechanism behind 
the proton abstraction of the C-terminal buried cysteine in these proteins has not been 
investigated until recently (Paper III). 
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AIMS OF STUDY 
 
The aim of this thesis has been to structurally and functionally characterize proteins 
involved in the class Ib RNR system. Detailed knowledge about the mode of interaction 
between different RNR proteins at the molecular level, as well as catalytic mechanism, is 
crucial for the development of antimicrobial drugs. X-ray crystallography, combined with 
biochemical analysis, QM/MM calculations, as well as different spectroscopic techniques 
provides detailed information about the structural and functional features of these enzymes.
 The M. tuberculosis class Ib RNR contains two genes encoding the small R2 
subunit, nrdF1 and nrdF2, encoding R2F-1 and R2F-2, respectively. The latter has 
previously been characterized, and assumed to be the only biologically active RNR small 
subunit. The lack of biochemical and biophysical data on the putative R2F-1 subunit lead 
us to carry out experiments corresponding to the first part of the thesis, involving 
biochemical and spectroscopic characterization of R2F-1.     
 In the second part of the project, an extensive crystallographic study of the B.
cereus class Ib RNR small subunit in complex with NrdI was performed. It has been of 
great interest for us to investigate this protein-protein assembly, in order to examine 
geometric and structural features, as well as to investigate the binding modes between 
these proteins.          
 The class Ib RNR operon from B. cereus lacks the nrdH gene, coding for the NrdH-
redoxin in other characterized class Ib RNRs. However, BC3987, a protein homologous to 
NrdH, has been located in the B. cereus genome. The presence of a Thr residue, also 
conserved in all NrdHs, was found located in the proximity of the C-X-X-C active site 
motif in BC3987, unlike in typical Trxs. This encouraged us to carry out a characterization 
of BC3987 and investigate the role of the Thr sidechain on the deprotonation of the C-
terminal buried Cys, in order to find a model for the enzymatic reaction mechanism in 
BC3987 and other similar Trx-like proteins. 
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SYMMARY OF PAPERS I-III 
 
Paper I 
Hammerstad, M., Røhr, Å. K., Andersen, N. H., Gräslund, A., Högbom, M., and 
Andersson, K. K. (2014) The class Ib ribonucleotide reductase from Mycobacterium
tuberculosis has two active R2F subunits. J. Biol. Inorg. Chem. DOI: 10.1007/s00775-014-
1121-x
This paper presents the first evidence for an active diferric tyrosyl radical (FeIII2-
Y•) cofactor in the M. tuberculosis class Ib RNR putative R2F-1 small subunit, supported 
by UV-vis, X-band EPR, and rRaman spectroscopy. Additionally, R2F-1, which was 
previously thought to be inactive, showed enzymatic activity when assayed with R1. 
 The first genetic and biochemical characterization of the class M. tuberculosis class 
Ib RNR was performed almost two decades ago by Rubin and coworkers (68). The study 
revealed the presence of two genes, nrdF1 and nrdF2, encoding the class Ib small subunit 
(R2F-1 and R2F-2, respectively). Since then, R2F-2 containing the FeIII2-Y• cofactor has 
been well characterized, and suggested to be the only R2 subunit able to form a functional 
class Ib RNR in M. tuberculosis with R1, thereby implying that R2F-1 is unable to 
substitute for R2F-2 in the active class Ib RNR system.     
 In this study, we have found that R2F-1 is able to generate an active FeIII2-Y• 
cofactor. X-band EPR studies reveal minor differences in the radical spectra when 
comparing the R2F-1-FeIII2-Y• with the previously characterized R2F-2-FeIII2-Y•, and the 
simulated EPR spectra of R2F-1 and R2F-2 display well resolved, nearly identical 
anisotropic proton hyperfine coupling parameters (hfc). The study also presents the first 
rRaman characterization of structural details associated with the Y• cofactor of R2F-1 and 
R2F-2 in M. tuberculosis, indicating that no exchangeable hydrogen atom is present 
adjacent to the radical. Most importantly, Fe-reconstituted R2F-1, when assayed with R1, 
revealed similar specific activity to that of R2F-2, comparable to previously published 
results for the latter. This suggests that the M. tuberculosis class Ib RNR can function with 
two biologically active small subunits. 
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Paper II 
Hammerstad, M., Hersleth, H. -P., Tomter, A. B., Røhr, Å. K., and Andersson, K. K. 
(2014) Crystal structure of Bacillus cereus class Ib ribonucleotide reductase di-iron NrdF 
in complex with NrdI. ACS Chem. Biol. 9 (2), 526–537 
The first crystal structure of the E. coli class Ib RNR NrdF subunit in complex with 
the flavoprotein NrdI was published by Boal et al. (97) in 2010, revealing the presence of a 
continuous channel connecting the FMN cofactor of NrdI with the NrdF MnII2 active site.
 In this paper, we present the first crystal structure of B. cereus NrdI-Fe2-NrdF. 
Compared to the E. coli NrdI-MnII2-NrdF crystal complex, our structure confirms similar 
NrdI-NrdF binding through a network of conserved residues lining the core interface in 
both structures. In the E. coli and B. cereus complex structures, these charged and polar 
residues create a similar hydrophilic channel, suggested to serve in transport of the 
hydrophilic oxidant, O2Ɣ-. This supports a conserved NrdI-NrdF binding in all class Ib 
RNRs, providing a general structural basis for cofactor activation.    
 The NrdI-Fe2-NrdF structure presented in this paper contains a di-iron site, 
differing from the NrdI-MnII2-NrdF structure from E. coli. Our work reveals a specific 
movement of a metal-coordinating carboxylate residue linked to the metal type present in 
the di-metal site, also supported by the B. cereus Fe2-NrdF and MnII2-NrdF crystal 
structures presented in this paper. In the NrdI-Fe2-NrdF and Fe2-NrdF structures, the 
carboxylate conformation seems to structurally block the access of an oxidant channeled 
from the FMN cofactor to the di-metal cofactor in NrdF. However, the carboxylate 
conformation seen in MnII2-NrdF crystal structures opens up for the water network leading 
to the di-metal site in NrdF, allowing oxidant access.     
 We further show that binding of NrdI to NrdF introduces steric clashes in the NrdI-
NrdF-NrdE formation, and discuss the potential mode of binding interactions between 
these proteins upon active cofactor generation and D2E2 holoenzyme formation. 
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Paper III 
Røhr, Å. K., Hammerstad, M., and Andersson, K. K. (2013) Tuning of thioredoxin redox 
properties by intramolecular hydrogen bonds. PLoS One 8 (7), e69411
In this paper, a small Trx-like protein from B. cereus, BC3987, has been 
characterized, and we have proposed a substrate reduction reaction mechanism for Trxs 
with a similar active site environment.       
 Together with certain other Trx-like proteins, BC3987 lacks the conserved 
carboxylate residue believed to function in deprotonation of the C-terminal cysteine, as 
proposed for the E. coli and A. aceti Trxs. However, BC3987 contains a Thr8 residue 
preceding the active site C-X-X-C motif, able to form a hydrogen bond to the buried 
cysteine. This residue has been shown to be conserved in other Trx-like proteins, such as 
NrdH-redoxins, and is believed to increase enzymatic activity, playing a central role in the 
reaction mechanism in these proteins.      
 Through biochemical assays comparing the wild type BC3987 with the Thr8Ala 
mutant, we have shown that the efficiency of substrate reduction is reduced for the mutant. 
Also, thiolate pKa titrations were performed comparing the wild type and Thr8Ala mutant 
enzymes. The results revealed that the wild type enzyme may have two titratable thiolates 
with different pKa values, 5.1 and 7.2, whereas the mutant enzyme has one thiolate with a 
pKa value of 7.2, and a second thiolate with a different behavior. Additionally, the mutant 
was shown to be unstable at pH values below 5.4.     
 The paper also presents the high resolution crystal structures of the wild type 
BC3987, as well as the Thr8Ala mutant with oxidized active sites. Based on these crystal 
structures, as well as crystal structures from other organism showing different Thr8 
rotamers, QM/MM calculations were performed in order to investigate the role of Thr8 in 
lowering of the buried cysteine pKa value. The calculations revealed that the Thr8 hydroxyl 
group and the Gln9 amide proton could form hydrogen bonds to the buried cysteine. Based 
on the modeling studies of the reduced active site, and the biochemical investigations 
performed in this work, a reaction mechanism model is proposed. This model involves 
deprotonation of the buried cysteine by the proximal Thr residue, proposed for Trxs 
lacking an analogue to the acidic Asp26 residue believed to participate in deprotonation of 
the C-terminal thiol in E. coli Trx. 
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MY CONTRIBUTIONS TO 
PAPERS I-III 
Paper I 
Designed and carried out most of the experiments (cloning, protein expression and 
purification, activity measurements, UV-vis spectroscopy, preparation of EPR -and 
rRaman samples, contribution to EPR experiments), analyzed the corresponding data, 
performed structural investigations and discussion, and wrote the manuscript.
Paper II 
Designed and carried out most of the experiments (protein expression and 
purification, single-crystal light absorption spectroscopy, protein crystallization and data 
collection), solved and refined several structures, investigated and analyzed 
crystallographic data, and wrote the manuscript.
Paper III 
Carried out experiments (in particular work with the T8A mutant protein), analyzed 
data and participated writing the manuscript. 
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DISCUSSION 
 
The main goal of my thesis has been to increase the knowledge of different proteins 
involved in the class Ib RNR, through structural, spectroscopic and biochemical 
investigations. In the following section, I will summarize the results presented in Papers I 
to III, and place these contributions in context with the ongoing research in the field of 
RNRs and other redox enzymes.         
 The discussion has been divided into four parts, starting with a short introduction to 
three of the biophysical techniques used; rRaman and EPR spectroscopy (Paper I), and X-
ray protein crystallography (Papers II and III). Thereafter, the different findings from 
Papers I to III will be discussed; the alternative R2F-1 RNR subunit in M. tuberculosis, the 
structure of the B. cereus NrdI-NrdF crystal complex, and the B. cereus BC3987 
thioredoxin. 
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A short introduction to biophysical 
techniques 
X-ray protein crystallography 
Crystallography is one of the most powerful methods used for visualization of 
three-dimensional images of molecules at atomic resolution. It can provide detailed 
structural information about functional aspects of proteins, such as conformational changes 
including metal coordination geometries, and mechanisms of binding.    
 In order to be able to visualize an object, light with the wavelength corresponding 
to the size of the objects is required. Atomic distances are in the 10-10 m range; hence, to 
resolve the positions of atoms within a molecule, X-ray radiation is required. In order to 
amplify the scattering signal, a prerequisite for solving a three-dimensional structure of a 
protein by X-ray crystallography is a well-ordered crystal that diffracts X-rays. Molecules 
pack in the crystal in an ordered pattern. Based on each equivalent point in the crystal, a 
unit cell can be defined. This three-dimensional array of molecules is described by the 
crystal lattice, whereas the whole symmetry of the lattice is defined by its space group. 
 The scattering of electromagnetic radiation from the electrons in a crystal, 
interfering constructively, generates a diffraction pattern, which can be used to determine 
the protein structure. The intensity of the diffraction spots depends on the position of atoms 
in the sample through which X-rays pass, and therefore, information about the molecular 
content of the unit cell. Since scattered X-ray beams in a diffraction experiment cannot be 
converted directly into an image as in conventional light microscopy, indirect 
computational procedures are crucial for structure determination. The structure factor is a 
function of the atomic content in the crystal, and sums up the scattering from all the 
electrons in the unit cell from each direction. Since the structure factor is the Fourier 
transform of the electron density, the electron density at every position in the unit cell can 
be calculated. One of the challenges in structure determination, however, is the fact that the 
time component of the scattered waves is lost during data collection. This is referred to as 
the phase problem. In order to solve the phase problem and hence, solve the structure by 
generating an electron density map, the approach used in this thesis has been “molecular 
replacement” (MR).         
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 For improvement of the atomic coordinates corresponding to the final structural 
model, structure refinement is performed in an iterative manner. The generated model is 
compared to the diffraction data, until any discrepancy between the two has reached a 
minimum. The correctness and quality of the structure is evaluated, and the agreement 
between the model and the experimental diffraction data is measured by the R-factor.   
Electron paramagnetic resonance spectroscopy 
As an important complement to structural determinations by X-ray crystallography, 
electron paramagnetic resonance (EPR or electron spin resonance (ESR)) is a 
spectroscopic technique used to study species containing unpaired electrons. It detects 
changes in electronic spin configuration and depends on the presence of a permanent 
paramagnetic moment, being a useful and sensitive method for studying paramagnetic 
active sites in metalloproteins and free radical intermediates. Hence, EPR can give intrinsic 
information about protein-bound metal ions, the geometry of ligand binding and redox 
changes in electron transfer mechanisms. Class Ia and Ib RNRs use a di-metal oxygen 
cluster for a generation of a stable tyrosyl radical, and is well suited for EPR 
investigations.           
 In the presence of a magnetic field, the magnetic moment of unpaired electrons will 
align either parallel or antiparallel to the field, corresponding to the two spin states of the 
electron, with different energies. Transitions between these two energy levels can be 
induced by providing electromagnetic radiation with energies corresponding to the energy 
difference between these two levels. In EPR spectroscopy, the absorption of microwave 
radiation is observed due to the excitation of electrons from one electronic spin to another. 
The energy is determined by the resonance conditions; hence, the splitting of the two 
energy levels can be described as a function of the applied magnetic field:  
ǻE = gEB = hv 
Where h is Planck’s constant, v is the frequency of the applied field (microwave), g is the 
electron g-factor, E is the Bohr magneton, and B is the external magnetic field.  
 The microwave radiation is absorbed due to a population difference in the energy 
levels involved, where the number of unpaired electrons in the lower energy level is 
greater than the number of electrons in the higher energy level. Thus, more transitions 
occur from the lower energy level state, resulting in a net absorption. In standard EPR, a 
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signal may be achieved by gradually increasing the magnetic field while applying 
electromagnetic radiation with a constant energy, hv, until the resonance condition is 
fulfilled. Amplitude modulation of the magnetic field with a fixed frequency results in the 
first derivative of the absorbed continuous wave (CW) EPR spectra. The EPR signal 
intensity is proportional to the population difference, which is dictated by the Boltzmann 
distribution. The amount of the studied species, such as free radical, can be determined by 
quantitation of the spin concentration through double integration of the EPR spectra. EPR 
measurements can be performed at different wavebands, most commonly at 9.6 GHz (X-
band), but also at higher magnetic field and microwave frequencies (HF-EPR), such as 95 
GHz (W-band), and at 285 GHz, important for separation of small g-tensor anisotropies. 
 The electron responds to the magnetic field, in addition to the surrounding field of 
atoms and molecules. The positions and splitting of the lines in the spectrum depend on the 
direction of the external field, relative to the molecular axes, called anisotropy. The 
symmetry of a spin center is reflected in its EPR signal g-anisotropy. Three g-values can 
result in splitting of the EPR signal, while the hyperfine couplings arising from the 
interaction of the unpaired electron with nearby nuclei spins, further split the fine structure 
of the spectra. 
Resonance Raman spectroscopy 
Resonance Raman (rRaman) spectroscopy is another powerful tool used to study 
the structure of metal ion environments in metalloproteins, as well as ligation modes of 
amino acid residues. In rRaman, the wavelength of the exciting laser is adjusted to 
correspond to a specific electronic transition in a molecule in order to increase the 
intensities of certain Raman bands. This makes the technique sensitive to changes in 
molecular bonding and conformations of specific structures, and can provide information 
about vibrational characteristics of metal centers and radicals. In RNR, the vibrational 
characteristics of tyrosyl radicals are sensitive to the presence of exchangeable hydrogens 
in the proximity of the phenoxyl oxygen. Therefore, the tyrosinate oxygen vibrational 
mode, ߥ෤͹ܽ  , is sensitive to the presence of a hydrogen bond. rRaman spectroscopy is a 
valuable tool for detection of changes in out-of-plane bond angles, as well as proximal 
electronic changes affecting the tyrosyl radical state. 
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The RNR class Ib R2F subunit 
For decades, the nature of the di-metal oxygen cluster and Y• cofactor in the small 
subunit of class I RNRs has triggered the curiosity of many scientists. Extensive 
characterization of these cofactors has been executed, gaining knowledge about metal-ion 
cluster identities, 3D structures, magnetic-optical properties, and reaction mechanisms. The 
bacterial class Ib R2F subunit is unique because of its ability to utilize different metal-ion 
clusters to generate a stable Y•, generating an active FeIII2-Y• cofactor or MnIII2-Y• 
cofactor. In the case of M. tuberculosis, the unusual and simultaneous presence of two R2F 
subunits was confirmed by Harvey Rubin and coworkers in 1997 (68). This led us to 
perform a biochemical and biophysical characterization of the second, putative R2F 
subunit R2F-1, in order to find out whether it could resemble the previously confirmed 
features of the well characterized R2F-2 subunit (Paper I). Despite the wide knowledge 
about the generation and nature of the FeIII2-Y• cofactor, a thorough understanding of the 
generation of the MnIII2-Y• cofactor is still not reached. Further complexity is also 
provided in the latter case, where the presence of an additional protein, NrdI, is needed as 
an electron donor for cofactor assembly. This encouraged us to investigate this protein-
protein association further, employing the crystal complex of NrdI-Fe2-NrdF from B.
cereus (Paper II). This gave additional knowledge about the structure of the metal ion 
coordination environment in R2F, in addition to the work published by Boal et al. (97) in 
2010, including the crystal complex of NrdI-MnII2-NrdF from E. coli. We have also shown 
insight into the mode of interaction between the different proteins in the active D2E2 
holoenzyme formation. In contrast to NrdI, which provides electrons used for generation of 
the MnIII2-Y• cofactor in R2F, Trxs function as electron donors for the catalytic subunit 
R1. NrdH-redoxins have been shown to function as specific reductants of the active site of 
R1 in class Ib RNRs. Since the class Ib RNR operon in B. cereus lacks the nrdH gene, we 
carried out a characterization of BC3987, proposing a model for the reaction mechanism in 
these Trx-like proteins (Paper III). 
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M. tuberculosis has two active R2F subunits 
The R2F-2 subunit of the class Ib RNR from M. tuberculosis was first shown to be 
active when assayed with the catalytic subunit almost two decades ago (68). The same 
study showed the presence of a Y• cofactor by EPR spectroscopy. Extensive EPR 
investigations of the R2F-2 subunit were later carried out by Gräslund and coworkers (159-
161), confirming similar features as previously observed in the class Ib R2F subunit from 
S. typhimurium (162). In contrast, the alternate M. tuberculosis R2F-1 subunit has been 
suggested to be unable to substitute for R2F-2 in the active class Ib RNR, despite the high 
sequence identity level. In Paper I, we have shown that iron-reconstituted R2F-1, 
containing the FeIII2-Y• cofactor, shows similar specific activity as compared to R2F-2, 
when assayed with R1. These results are the first to demonstrate catalytic activity of the 
second putative R2F-1 subunit in M. tuberculosis, consistent with previously reported 
activity for R2F-2 (68). Both nrdF1 and nrdF2 genes have been shown to be expressed at 
similar levels in aerobic conditions (69), however, loss of the nrdF1 gene has no 
significant effects on the cell viability or virulence (71). Therefore, the results from Paper 
I, confirming R2F-1 activity with R1, raise questions about the biological role of R2F-1, 
and hence, the aspect of a simultaneous presence of two active small RNR subunits in M.
tuberculosis. One explanation could be changes in affinity for metal ion incorporation 
among the two subunits, during distinct growth conditions. For example, R2F-2 could be 
preferred as the active MnIII2-Y• cofactor generating subunit in Mycobacteria living in 
their natural habitats, such as soil or water, whereas R2F-1 could act as the preferred 
subunit responsible for generation of an active FeIII2-Y• cofactor used for nucleotide 
reduction during mammalian lung infection. Further investigations are required in order to 
elucidate the biological role of R2F-1. M. tuberculosis is the first species shown to 
simultaneously express two active class Ib RNR R2F subunits. 
Spectroscopic characterization of R2F-1 
In agreement with similar specific activity shown for R2F-1 and R2F-2, and based 
on conserved metal coordinating -and tyrosine residues present in both subunits, X-band 
EPR spectra of R2F-1 and R2F-2 presented in Paper I reveal nearly identical features. Not 
surprisingly, the EPR spectra of the R2F-1-FeIII2-Y• and the R2F-2-FeIII2-Y• strongly 
resemble the spectrum of R2F-2-FeIII2-Y• previously characterized by Gräslund and 
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coworkers (159), which was also characterized by HF-EPR. Based on the latter results, we 
assume that the Y• in R2F-1 has the same g-tensor components as R2F-2. EPR spectra 
simulations reveal nearly identical anisotropic hyperfine coupling parameters (hfc), and the 
dihedral angle, T , describing the orientation of the D-carbon of the tyrosine ring plane, for 
the Y•  in R2F-1 and R2F-2 is estimated to be around 75°. This is similar to the T -angle in 
the previously characterized M. tuberculosis R2F-2 and S. typhimurium (162). 
Additionally, rRaman spectroscopy indicates the absence of a hydrogen bond to the 
tyrosyl-oxygen radical in R2F-1 and R2F-2. The findings in Paper I suggest that R2F-1 and 
R2F-2 both can function as radical generating subunits in the class Ib RNR in M.
tuberculosis, with similar activity, supported by nearly identical spectroscopic features of 
their FeIII2-Y• cofactors. 
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B. cereus NrdF and the NrdI-NrdF crystal 
complex 
In Paper II, we have investigated the structural mode of binding between NrdF and 
NrdI in the class Ib RNR form B. cereus, as well as examined the structural features 
suggested to play a role upon active MnIII2-Y• cofactor generation in NrdF. Six crystal 
structures were obtained for this purpose: two structures of Fe2-NrdF in complex with 
NrdI, Fe2-NrdF, MnII2-NrdF, and two structures of apo-NrdF.    
 The B. cereus NrdI-Fe2-NrdF crystal complex reveals structural similarity as 
compared to the E. coli NrdI-MnII2-NrdF crystal complex (97) (with an RMSD value of 
1.42 Å calculated for the monomeric NrdI-NrdF complexes) (Figure 12A), suggesting 
similar binding of NrdI to NrdF in class Ib RNRs. The similar overall interaction between 
NrdI and NrdF is also supported by the high level of conservation of the amino acids lining 
the NrdI-NrdF interface (Figure 12B), a general attribute for all class Ib RNRs. These 
charged and polar residues are suggested to form a hydrophilic solvent channel, connecting 
the FMN cofactor in NrdI with the di-metal site in NrdF, proposed to serve in the 
channeling of a hydrophilic oxidant (O2Ɣ-) needed for generation of the active MnIII2-Y• 
cofactor (Figure 12C). The core interface is likely essential for recognition between NrdFs 
and NrdIs, suggesting that the NrdI-NrdF complex is important for generation of the 
hydrophilic channel preceding electron transfer. We propose that amino acid differences 
outside the conserved core region are important for the small variations observed in the 
NrdI-NrdF binding in E. coli and B. cereus, where the association is much stronger in E. 
coli than in Bacillus species (18,87,95,98). The conserved core interface region is not 
present in bacterial class Ia NrdB, neither in the eukaryotic R2s.  
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Figure 12. Structure of the NrdI-NrdF complex. (A) Alignment of the overall B. cereus and E. coli 
(PDBid:3N39) (97) NrdI-Fe2-NrdF and NrdI-MnII2-NrdF structures, respectively. (B) Alignment of 
the conserved hydrogen bonding network in the NrdI-NrdF core interface, and the (C) solvent 
channel connecting the FMN cofactor in NrdI with the di-metal cluster in NrdF, in B. cereus and E.
coli. B. cereus NrdI is shown in yellow, NrdF is shown in pink, while the E. coli structure is shown 
in grey. The FMN cofactor, as well as the residues in the active site of NrdF are shown as sticks 
and colored by atom type. Fe (B. cereus) and MnII (E. coli) ions are shown as orange and purple 
spheres, respectively. 
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Flexibility of the metal ion coordination environment 
In the E. coli and B. cereus complexes, the proposed solvent channel is structurally 
conserved, extending from NrdI to the vicinity of metal site 2 in NrdF. However, in the B.
cereus NrdI-Fe2-NrdF crystal complex, the channel is prevented from accessing the Fe2-
NrdF metal site due to structural differences in the metal coordination environment, as 
compared to the E. coli NrdI-NrdF complex crystallized with manganese. The access 
seems to be blocked by the bidentate coordination to metal site 2 by Glu161 (B. cereus 
numbering), observed in both NrdI-Fe2-NrdF crystal structures (Figure 13), where one of 
the structures contain alternative Glu161 conformations, likely due to the lower iron 
occupancy (50%, as compared to 90% for the first structure). The same Glu161 
coordination is also observed for the B. cereus Fe2-NrdF structure presented in Paper II (as 
well as the two apo-NrdF structures), where Glu161 coordinates to Fe2 in a mono -or 
bidentate fashion (monomers B and A, respectively).  
 
Figure 13. Structures of the Fe2-NrdF and MnII2-NrdF active sites in B. cereus and E. coli 
(PDBid:3N39) (97), showing differences in the Glu161 (B. cereus numbering) conformation. The 
bidentate coordination of Glu161 to Fe2 in B. cereus occupies the terminal part of the solvent 
channel. In contrast, the E. coli Glu158 bridges both metals in a μ-1,3 fashion, opening up for a 
water ligand thought to be part of the ordered water network connecting FMN in NrdI to the di-
metal site in NrdF (See Figure 12C). The B. cereus residues are shown as pink sticks, while the E.
coli residues are shown in grey. 
 
This feature is consistent with other class Ib NrdF crystal structures, showing the same 
channel-blocking Glu161 coordination mode. In contrast, crystal structures of the E. coli 
NrdI-MnII2-NrdF crystal complex and the MnII2-NrdF structure, as well as the B. cereus 
MnII2-NrdF structure from Paper II (the latter showing conformational flexibility), show an 
unusual Glu161 coordination, involving bridging of both metals in a μ-1,3 fashion (Figure 
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13). This conformation differs from other class Ib NrdF structures, where Glu coordinates 
to metal site 2 alone. In the case of the B. cereus and E. coli Mn-containing NrdF 
structures, the Glu161 conformation opens up for a water coordinating to the Mn2 site and 
the extended ordered water network connecting the FMN cofactor to the NrdF metal site, 
facilitating transport of O2Ɣ-. These findings indicate that the movement of Glu161 can be 
linked to the metal type present in the metal ion site of NrdF, showing flexibility of the 
Glu161 conformation. The flexibility in key coordinating residues of the NrdF di-metal site 
suggests that different active site geometries can serve as starting points for 
metallocofactor activation, where Glu161 seems to specifically distinguish between the 
different Fe -or Mn containing structures. Similar NrdI binding to NrdF in the B. cereus 
and E. coli NrdI-Fe2-NrdF and NrdI-MnII2-NrdF complexes, respectively, suggests the 
same general binding interface in all class Ib RNRs, independent of metal ion type bound 
in NrdF. 
Assembly of the class Ib holoenzyme 
In Paper II, we further report that NrdI-NrdF binding likely affects the formation of 
the NrdF-NrdE holoenzyme. The B. cereus NrdI-NrdF complex supports similar binding 
between these two proteins in all class Ib RNRs. Based on a structural alignment of the 
latter structure with the E. coli class Ia D2E2 holoenzyme structure (78) (see Figure 6A), we 
suggest that binding of NrdI to NrdF introduces steric clashes disturbing D2E2 holoenzyme 
formation. Since studies also support an active D2E2 holoenzyme stoichiometry for the 
class Ib RNR assembly, the results from Paper II indicate that activation of the MnIII2-Y• 
cofactor must occur in an initial stage, prior to NrdF-NrdE interaction in the active R2-R1 
complex. Consequently, NrdI would dissociate prior to NrdF binding to NrdE, not 
interfering with the binding of these subunits. This requirement could possibly explain the 
inhibitory effect of NrdI present during activity assays performed with Fe-NrdF and NrdE 
from E. coli, in which a tight association between NrdI and NrdF has been reported (18). 
This association has been shown to be weak in Bacillus species, and a similar inhibitory 
effect of NrdI has not been observed. Hence, the weaker NrdI-NrdF binding in Bacillus 
likely makes NrdF more accessible for NrdE binding. Consequently, these studies also 
indicate differences in binding strength and the mode of interaction among different 
species. Moreover, the presence of NrdI does not influence the binding of NrdH-redoxin to 
NrdE (87,95,98). Further studies are required in the investigation of the class Ib RNR 
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interactions. The conserved binding interface between NrdIs and NrdFs, as well as NrdFs 
and NrdEs, could be of great importance related to the development of antimicrobial drugs 
and class Ib RNR inhibition. 
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B. cereus BC3987 – a small thioredoxin 
NrdH-redoxins, as well as the B. cereus BC3987 redoxin, lack the acidic residue 
similar to Asp26 in E. coli and A. aceti Trx, believed to participate in deprotonation of the 
C-terminal cysteine. A phylogenetic analysis performed in Paper III revealed the presence 
of several conserved residues preceding the C-X-X-C active site motif in Trx-like proteins. 
These often include highly conserved Asp, Thr and Ser residues, shown to affect the 
catalytic activity, or proposed to do so. The Cp9, NrdH and BC3987 redoxins all contain a 
conserved threonine residue, Thr8 (BC3987 numbering), four amino acid residues 
preceding the active site motif. In Paper III, we have investigated how hydrogen bonding 
by Thr8 to the deprotonated thiol affects the C-terminal cysteine pKa value, making the 
second nucleophilic attack on the substrate possible by these Trx-like proteins. This has 
been performed through a comparison of the wild type BC3987 with a Thr8Ala mutant 
protein. 
Cysteine pKa values can be adjusted through hydrogen 
bonding 
The BC3987 wild type and Thr8Ala mutant structures were obtained at high 
resolution, revealing the typical D/E/D Trx fold, as also seen for the E. coli (122), C.
ammoniagenes (163), and M. tuberculosis (157) NrdH structures. The C-P-P-C active site 
motif differs from what is typically observed in Trxs and Grxs. As seen from the crystal 
structures of BC3987, a Thr53 residue is also found in the proximity of the active site 
motif, possibly acting as a hydrogen bond donor. It is clear from the structure that the Gln9 
amide proton is within hydrogen bonding distance to the Cys15 SJ-atom. In contrast, the 
Thr8 residue in the vicinity of the active site motif of the wild type structure shows a 
different rotamer (Figure 14A), as compared to the previously reported structures of NrdH-
redoxins from E. coli and C. ammoniagenes. In BC3987, the hydroxyl group of Thr8 is 
pointing away from the buried Cys15 SJ-atom, stabilized by a nearby water molecule. In 
the M. tuberculosis NrdH structure, Thr8 is present in two alternative conformations, 
corresponding to the conformations present in both E. coli and C. ammoniagenes NrdH 
(40% occupancy), as well as B. cereus BC3987 (60% occupancy). In order to investigate 
whether this Thr8 residue, as well as the Thr53 hydroxyl group, could contribute in 
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lowering of the buried cysteine pKa value through hydrogen bonding, QM/MM modeling 
including the whole protein was performed. Two models of the reduced active site were 
obtained; Model I, where Thr8 has the same rotamer as seen in the BC3987 crystal 
structure, pointing away from the buried Cys15 SJ-atom; and Model II, where the 
conformation of Thr8 resembles the rotamers seen in the NrdH-redoxin structures from E.
coli and C. ammoniagenes, pointing towards the buried Cys15 SJ-atom (Figure 14B). 
 
 
Figure 14. The BC3987 active site environment. (A) Crystal structure of the oxidized active site 
environment, displaying the C-X-X-C disulfide bridge, Thr8 and Thr53 side chains, and the Gln9 
amide. (B) The reduced active site environment from QM/MM Model II, where the Thr8 side chain 
has been rotated to resemble the rotamer observed in E. coli and C. ammoniagenes NrdH-redoxins. 
The Gln9 amide proton and Thr8 hydroxyl group appears to form hydrogen bonds to the C-
terminal Cys15 side chain, while the N-terminal Cys12 side chain hydrogen bonds to the Cys15 
amide proton. 
 
Both models suggest that the N-terminal Cys12 side chain is hydrogen bonded to the 
Cys15 amide proton, likely explaining the lowered pKa value of this thiol, making it 
suitable to perform the initial nucleophilic attack on the substrate disulfide bond. From 
both models, it is also clear that the buried Cys15 thiolate can make a hydrogen bond to the 
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Gln9 amide proton. While the predicted contribution from Thr53 is small in both models, 
Model II reveals an additional hydrogen bond to the buried cysteine thiolate from Thr8. 
The calculated pKa values from Model II for Cys12 and Cys15 are 7.1 and 6.4, 
respectively, whereas the Cys15 pKa value calculated from Model I is higher (8.0). These 
results are compatible with the experimental results from Paper III, where the pKa values of 
the active site cysteines were estimated using reduced samples of wild type BC3987 and 
the Thr8Ala mutant, compared with oxidized references. The pH-titration experiments 
indicate that the N-terminal Cys12 pKa value is the same for the wild type and mutant 
proteins, with a pKa value of 7.2. In contrast, the wild type BC3987 appears to have a 
lowered pKa value for the C-terminal Cys15 thiolate of 5.1, indicating that BC3987 has two 
thiolates with titratable pKa values of 7.2 and 5.1, similar to the values calculated from 
Model II (pKa values of 7.1 and 6.4). The Thr8Ala mutant, however, was shown to be 
unstable, leading to protein precipitation at pH values below 5.4, indicating that the Cys15 
thiolate behaves differently as compared to the wild type.  Paper III also reveals that the 
wild type BC3987 Trx is a more efficient insulin disulfide reductant as compared to the 
Thr8Ala mutant. Based on these results, we suggest that the lowered pKa value of the 
buried cysteine can be explained through hydrogen bonding to the Thr8 side chain and the 
Gln9 amide proton. These studies are contrary to what is proposed based on the structural 
investigation of the M. tuberculosis NrdH structure (157), suggesting that the Thr8 OH 
group can only face the disulfide of the active site motif in the oxidized form, due to lack 
of space to accommodate the Cys15 thiol group in the reduced form. Based on our results 
suggesting that the deprotonated thiolate form of Cys15 is stabilized by Thr8 and Gln9, we 
propose a reaction mechanism (see Figure 7 in Paper III) for BC3987. This mechanism is 
likely also with respect to other Trx-like proteins lacking the acidic residue analogous to 
the E. coli Trx Asp26. The B. cereus BC3987 redoxin has also been shown to promote 
high catalytic activity in the B. cereus and B. anthracis Mn-reconstituted class Ib RNR 
(87). 
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FUTURE PERSPECTIVES 
 
In order to explain additional aspects regarding the RNR system, studies of the M.
tuberculosis and B. cereus class Ib RNR is ongoing in our group. B. cereus contains three 
annotated FNRs and one TrxR. While the role of TrxR in transferring electrons from 
NADPH to Trx has been thoroughly studies, the targets of the reducing power provided by 
the FNRs are not fully established. Preliminary results indicate that one of these FNRs can 
act as an electron donor for the class Ib RNR protein NrdI. Other FNRs might function as 
unspecific reductases with other protein partners, such as nitric oxide synthase (NOS). The 
relationship between the different proteins participating in the class Ib RNR system, such 
as FNRs, flavodoxins, NrdF and NrdE needs further investigations in order to map the 
network. Activity assays, as well as extensive thermodynamic characterization using 
isothermal calorimetry (ITC) are useful tools for describing the interactions between these 
accessory proteins, as well as NrdF and NrdE in combinations with allosteric effectors and 
substrates.           
 A broader understanding of the structural basis of the interactions and specificity 
between the above mentioned redox partners is further needed. The crystal structure of the 
NrdI-NrdF complex in Paper II provided interesting knowledge about the association 
between these proteins. However, such knowledge should also be addressed for other 
protein partners in the system, in order to understand how these proteins recognize and 
associate with each other. We are currently working on crystallization trials with several of 
the above mentioned proteins, where crystallization of protein complexes has been 
considered crucial. Co-crystallization of different protein complexes will be supplemented 
with standard biochemical analysis, as well as spectroscopic studies such as UV-vis, 
rRaman and EPR spectroscopy.        
 Although the M. tuberculosis R2F-1 subunit has been biochemically and 
spectroscopically characterized in Paper I, there is no crystal structure of R2F-1 available 
in the PDB database. A crystal structure of R2F-1 would provide useful information about 
this protein, when compared to the M. tuberculosis R2F-2 subunit and other class Ib small 
subunits. It is also of interest to investigate whether the two small subunits of the M.
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tuberculosis class Ib are able to generate active MnIII2-Y• cofactors. Comparisons of the 
class Ib RNR proteins to the eukaryotic RNR system will be performed, including studies 
involving the p53R2 subunit (66). 
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ABSTRACT: Class Ib ribonucleotide reductases (RNRs) use a dimetal-tyrosyl radical (Y•) cofactor in their NrdF (β2) subunit
to initiate ribonucleotide reduction in the NrdE (α2) subunit. Contrary to the diferric tyrosyl radical (Fe
III
2-Y•) cofactor, which
can self-assemble from FeII2-NrdF and O2, generation of the Mn
III
2-Y• cofactor requires the reduced form of a ﬂavoprotein,
NrdIhq, and O2 for its assembly. Here we report the 1.8 Å resolution crystal structure of Bacillus cereus Fe2-NrdF in complex with
NrdI. Compared to the previously solved Escherichia coli NrdI-MnII2-NrdF structure, NrdI and NrdF binds similarly in Bacillus
cereus through conserved core interactions. This protein−protein association seems to be unaﬀected by metal ion type bound in
the NrdF subunit. The Bacillus cereusMnII2-NrdF and Fe2-NrdF structures, also presented here, show conformational ﬂexibility of
residues surrounding the NrdF metal ion site. The movement of one of the metal-coordinating carboxylates is linked to the metal
type present at the dimetal site and not associated with NrdI-NrdF binding. This carboxylate conformation seems to be vital for
the water network connecting the NrdF dimetal site and the ﬂavin in NrdI. From these observations, we suggest that metal-
dependent variations in carboxylate coordination geometries are important for active Y• cofactor generation in class Ib RNRs.
Additionally, we show that binding of NrdI to NrdF would structurally interfere with the suggested α2β2 (NrdE-NrdF)
holoenzyme formation, suggesting the potential requirement for NrdI dissociation before NrdE-NrdF assembly after NrdI-
activation. The mode of interactions between the proteins involved in the class Ib RNR system is, however, not fully resolved.
Ribonucleotide reductases (RNRs) catalyze the conversionof ribonucleotides to their corresponding deoxyribonu-
cleotides in all living organisms, providing the essential building
blocks required for DNA replication and repair.1,2 Class I RNRs
consist of two homodimeric subunits: α2 and β2. Nucleotide
reduction is initiated through the reversible one-electron
oxidation of a conserved cysteine residue to a thiyl radical in
the α2 subunits, initiated by a dinuclear metallocofactor and
tyrosyl radical positioned in the β2 subunits.
3 Three subclasses
of the class I enzymes have been characterized based on their
metal ion composition and sequence: Ia, Ib, and Ic.4 The class
Ia RNRs are found in eukaryotes, some viruses, and some
prokaryotes such as Escherichia coli (Ec) (the latter also
containing the class Ib RNR), supplying deoxyribonucleotides
during normal aerobic growth.3,5 Enzyme activity requires a μ-
oxo-bridged diferric tyrosyl radical (FeIII2-Y•) cofactor localized
in the β2 subunit (NrdB/R2).
6 The cofactor can be formed by
self-assembly from apo-NrdB in the presence of FeII and O2,
forming the Y• required for dNDP formation in the α2 subunits
(NrdA/R1).7 The class Ic RNR has so far been well
characterized only in the obligate intracellular pathogen
Chlamydia trochomatis. Subsequent studies have shown that
its β2 subunit utilizes a stable, heterodinuclear Mn
IVFeIII
cofactor to initiate catalysis.8−11 Class Ib RNRs are the primary
sources of dNTPs for a wide variety of prokaryotes, such as
Mycobacterium tuberculosis (Mt), Corynebacterium ammoniagenes
(Ca), Bacillus anthracis (Ba), Bacillus subtilis (Bs), and Bacillus
cereus (Bc).12 The class Ib enzymes consist of the α2 (NrdE/
R1E) and β2 (NrdF/R2F) subunits,
13 where the active form in
both class Ia and class Ib is believed to comprise an α2β2
stoichiometry.14,15 The metallocofactor required for activity in
class Ib RNRs has for several decades been known to consist of
an FeIII2-Y• cofactor, assembled in vitro similarly to the class Ia
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enzymes.16,17 However, recent studies have shown that the class
Ib NrdF can also utilize an active MnIII2-Y• cofactor for
nucleotide reduction.18−20 The MnIII2-Y• cofactor can only be
generated from the dimanganese(II) site (MnII2) in a self-
assembly process in the presence of O2 and the ﬂavodoxin-like
protein NrdI.18 NrdI is found in all organisms with genomes
coding for the class Ib RNR21 and contains a ﬂavin
mononucleotide cofactor (FMN), demonstrated to be able to
act as a two-electron reductant.22,23 It has been proposed that
NrdI, in its fully reduced hydroquinone form (NrdIhq,
containing FMNH−), reacts with O2 providing the oxidant,
H2O2 or O2•−, required for generation of the active MnIII2-Y•
cofactor.24−26 Studies have shown that the MnIII2-Y• cofactor
can be formed both in vitro and in vivo,20,24 and that the
manganese form of the enzyme has a higher speciﬁc activity
compared to the iron form, as in the case of Ba,27 Bc,28 and
Bs,29 all showing a 10-fold diﬀerence. It is still not understood
how the in vitro process of cofactor assembly using identical
metal coordinating ligands, but diﬀerent metals and oxidants,30
is controlled in vivo. Structural studies of Ec NrdF both in the
FeIII2 and Mn
III
2 forms, as well as of the crystal structure of the
MnII2-NrdF in complex with NrdI, give insight into Y•
generation in NrdF.25 The metal-binding residues are identical
in most class Ia and Ib RNRs, where the dimetal clusters are
coordinated by four carboxylates and two histidines.31 The
coordination environment in structures of Ec MnII2-NrdF and
NrdI-NrdF complexes revealed an unusual structural feature
involving Glu158 (Ec numbering), showing bridging of both
metals in a μ-1,3 fashion.25 This carboxylate conformation
observed in the Ec structures is diﬀerent from other reported
RNR class I structures, where the corresponding Glu
coordinates to metal site 2 alone. In these structures, Glu
occupies the site of a Mn2 water ligand thought to be part of an
ordered water network facilitating transport of the reactive
oxidant from the NrdI ﬂavin cofactor to the NrdF metal site,
required for the generation of the MnIII2-Y• cofactor.18
Here, we present the ﬁrst crystal structure of the Bc class Ib
NrdF in complex with the ﬂavoprotein NrdI. In this 1.8 Å
resolution crystal structure, the Bc NrdF is in the Fe2 form, and
the Glu161 (Bc numbering) coordinates to only metal site 2, as
seen for most class Ib NrdF structures. This is in contrast to
what was observed in the Ec MnII2-NrdF and NrdI-Mn
II
2-NrdF
structures, where Glu bridges both metals in a μ-1,3 fashion
opening up for an ordered water network to the FMN site. In
both the Bc NrdI-Fe2-NrdF and Fe2-NrdF structures, this water
network and channel is blocked by the bidentate coordination
of Glu161 only to the Fe2 site. However, in the Bc MnII2-NrdF
crystal structure, also presented here, Glu161 shows variations
in this carboxylate conformation, with one conformation
bridging both metals in a μ-1,3 fashion, revealing the water
network. The carboxylate variations in the diﬀerent NrdI-NrdF
complexes, as well as NrdF structures, indicate that ﬂexibility in
coordinating amino acids is possible, almost in a gating fashion,
and is likely important for metal cofactor and tyrosyl radical
generation.
■ RESULTS AND DISCUSSION
In this work, we present six crystal structures of the Bc class Ib
RNR small subunit NrdF, including two structures of NrdF in
complex with NrdI (NrdI-NrdF-1 and -2), Fe2-NrdF, Mn
II
2-
NrdF, and two structures of apo-NrdF (apo-NrdF-1 and -2).
Overall Structure of the Bc Fe2-NrdF, Mn2-NrdF, and
NrdI-NrdF Complex. Both the 2.1 Å (NrdI-NrdF-1) and 1.8
Å (NrdI-NrdF-2) resolution crystal structures of Bc NrdI-NrdF
were obtained by co-crystallizing NrdF with an equimolar
amount of NrdI. The asymmetric unit contains one monomer
of NrdI in complex with one monomer of NrdF, in which the
overall architecture strongly resembles the Ec NrdI-NrdF
structure reported earlier by Boal et al.25 The overall structure
of the 2.1 Å resolution Bc NrdI-NrdF protein complex is shown
in Figure 1A and C, while a structural alignment of the Bc and
Ec NrdI-NrdF complexes is shown in Figure 1B and
Supplementary Figure S1. Structural similarity between the Bc
and Ec monomeric NrdI-NrdF complexes has been calculated
to an RMSD value of 1.42 Å, while structural similarity between
the dimeric NrdI-NrdF structures have an RMSD of 1.78 Å.
The RMSDs for the Bc and Ec NrdF and NrdI structures
individually (from the crystal complexes) are 1.23 and 1.05 Å,
respectively. This shows that the NrdF and NrdI bind similarly
to each other in Ec and Bc, but with some small structural
variations (see below). The ﬁnal model for NrdI-NrdF-1
consists of residues 1−290 out of 322 in NrdF and residues 1−
117 out of 119 in NrdI and are reﬁned to ﬁnal Rwork/Rfree values
of 17.7%/23.3%. The NrdI-NrdF-2 structure consists of
residues 1−290 in NrdF and 1−118 in NrdI and are reﬁned
to ﬁnal Rwork/Rfree values of 16.7%/20.9%. Both the NrdI-NrdF
and the diﬀerent NrdF structures show well-deﬁned electron
density for the modeled residues. The 2.1 and 1.9 Å resolution
crystal structures of Bc Fe2-NrdF and Mn
II
2-NrdF, respectively,
contain two molecules in the asymmetric unit, with the ﬁnal
models consisting of residues 1−287 out of 322 in monomers A
Figure 1. Structure of the NrdI-NrdF complex. (A) The overall structure of the Bc NrdI-Fe2-NrdF complex and (B) alignment of the Bc and Ec
(PDB id: 3N39) NrdI-Fe2-NrdF and NrdI-Mn
II
2-NrdF complexes, respectively. (C) The dimeric Bc NrdI-Fe2-NrdF complex, represented by the
monomeric Bc NrdI-Fe2-NrdF (asymmetric unit) shown with its symmetry equivalent molecule. The FMN cofactor in NrdI and the residues in the
active site of NrdF are represented as sticks and colored by atom type in Bc and colored gray in Ec. Fe ions are shown as orange spheres (Bc), and
MnII ions are shown as purple spheres (Ec).
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and B for both structures. The structures are reﬁned to ﬁnal
Rwork/Rfree values of 18.5%/23.5% and 21.0%/26.0%, respec-
tively. The two Bc apo-NrdF structures belong to diﬀerent
crystal forms. Apo-NrdF-2 (2.0 Å) belongs to space group P21
as the Bc Fe/Mn-NrdF structures and contains residues 1−
287/1−288 for the two monomers with ﬁnal Rwork/Rfree values
of 20.8%/26.0%. Apo-NrdF-1 (2.2 Å) belongs to space group
C2, also consisting of two monomers, and was reﬁned to ﬁnal
Rwork/Rfree values of 17.6%/24.3%. The overall structure of Bc
NrdF in the diﬀerent NrdI-NrdF and NrdF structures
presented here are very similar (Supplementary Figure S2A).
However, residues 26-31 in NrdI-NrdF-1 and monomer B of
apo-NrdF-1 have a more helical conformation compared to the
other structures (Supplementary Figure S2C and D). Due to a
diﬀerent crystal packing, 13 more residues of the ﬂexible C-
terminal end were built into the electron density of monomer A
of apo-NrdF-1 (Supplementary Figure S2B), with the two
resulting monomers containing residues 1−300/1−287,
respectively. These additionally built in residues point into
the area where interaction with NrdE is suggested,14 indicating
that the ﬂexible C-terminal could become ordered through
interaction with NrdE.
Structure and Coordination Environment of the
Crystal Complex Metal Cluster Site. The overall structure
of the metal cluster coordination site in the Bc NrdI-NrdF
structure strongly resembles other class Ib NrdF struc-
tures,13,19,30,32,33 except for the Ec MnII2-NrdFs
25 and the Bc
MnII2-NrdF presented in this paper. Both Bc NrdI-NrdF
complex structures have been obtained with iron in the NrdF
dimetal sites (Figure 2). For the NrdI-Fe2-NrdF-1 structure
modeled with 90% iron occupancy, the Fe sites are four- and
ﬁve-coordinated, respectively, with an Fe−Fe distance of 3.9 Å,
Glu195 in a μ-1,3 coordination, and Glu161 bidentate to Fe2
(Figure 2A, C, and E). The coordination and the long Fe−Fe
distance is consistent with previously reported ferrous (FeII)
iron NrdF/B structures.13,19,30,32,33 The Fe omit map shown in
Figure 2C and D and the anomalous diﬀerence map at 1.0 Å
wavelength conﬁrm the presence of metals in the di-Fe sites
(Figure 2E and F). In the 1.8 Å NrdI-Fe2-NrdF-2 structure,
similar coordination and Fe−Fe distance is observed; however,
additional alternative conformations are modeled for Glu195,
Glu93, and Glu161 (Figure 2B, D, and F). This could partly be
due to the lower iron occupancy in the di-Fe sites (50%). The
X-ray doses absorbed by the diﬀerent crystals in this study
(Table 1) are within the recommended Henderson limit of 20
MGy to avoid considerable radiation damage of protein
crystals.34 Nevertheless, X-ray induced radiation damage of
metal sites occurs on a much shorter time scale.35 Studies on
RNR have shown a fast reduction of the oxidized metal ion
states;36,37 however, the structures presented here are
considered to already be in the reduced states, and therefore
X-ray induced changes are limited.
Bc Fe2-NrdF Coordination Environment. The crystal
structure of the dimeric Bc Fe2-NrdF has been modeled with
Figure 2. Metal ion sites in the two Bc NrdI-Fe2-NrdF complex structures. (A, C, and E) The metal site in NrdI-Fe2-NrdF-1 and (B, D, and F) the
metal site in NrdI-Fe2-NrdF-2. The Fe ions are shown as orange spheres, and the coordinating amino acids and Tyr100 are represented as sticks and
colored by atom type. In panels C and D, the 2Fo−Fc electron density map (gray) is contoured at 1σ, while the Fo−Fc map is shown as green mesh
(3σ) and red mesh (−3σ). The omit map surrounding the Fe ions is contoured at 6σ (salmon). The Fe ions are modeled with 90% (C) and 50%
(D) occupancy. For panels E and F, anomalous maps are included, contoured at 3.5σ (brown).
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full metal occupancy at the dimetal sites. The higher B-factor of
the Fe1 sites in Fe2-NrdF could indicate lower occupancy. The
di-Fe sites in the ferrous soaked NrdF structure have higher
coordination compared to the NrdI-Fe2-NrdF structures
(Figures 2, 3, and 4A). For monomer A, contrary to NrdI-
Fe2-NrdF-1, Glu195 has moved to a μ-(η
1-η2) coordination
opening up for a water coordinating to Fe1 instead of a water
molecule hydrogen-bound to Tyr100, the residue responsible
for tyrosyl radical (Y•) generation in Bc. This results in the Fe
sites becoming ﬁve- and six-coordinated, respectively, diﬀering
from what has been observed by circular dichroism and
magnetic circular dichroism on RNR protein solutions.2,38 The
μ-(η1-η2) coordination of Glu195 (Bc numbering) in Bc Fe2-
NrdF is also observed in Ec FeII2-NrdB (without the water
coordinating to Fe1) and in EcMnII2-NrdF structures, while the
FeII2-NrdF structures from Ca, Salmonella typhimurium (St),
Mt, and the MnII2-NrdF structures from Ca, Ec, and Bs all show
the μ-1,3 coordination (Figure 4B).13,25,30,32,33 In monomer B
of Bc Fe2-NrdF, Glu161 coordinates to Fe2 in a monodentate
way instead of bidentate, resulting in both di-Fe sites being ﬁve
coordinated (Figure 3A−D).
Bc MnII2-NrdF Coordination Environment and Glu161
Movement. The Bc MnII2-NrdF structure has been modeled
with full occupancy at the dimetal sites (except for Mn2 in
monomer A with 90% occupancy) (Figure 3E−H) and shows
higher coordination for the dimetal site than in the Bc Fe2-
NrdF with both Mn-sites being six-coordinated similar to what
is observed in Ec. In the Bc MnII2-NrdF structure, Glu161
shows great ﬂexibility. Two and three alternative conformations
have been modeled at the Glu161 site in monomers A and B,
respectively. In monomer A, one coordinates to metal site 2
alone, in a bidentate fashion (33%) as seen in the Bc Fe2-NrdF
Table 1. Data Collection and Reﬁnement Statistics
Bc MnII2-NrdF Bc Fe2-NrdF Bc NrdI-NrdF-1 Bc NrdI-NrdF-2
Crystal Data
space group P21 P21 C2221 C2221
a, b, c (Å) 61.9/49.2/98.5 62.0/49.3/98.5 59.3/125.0/142.6 59.5/124.7/141.3
α, β, γ (deg) 90.0/107.2/90.0 90.0/107.2/90.0 90.0/90.0/90.0 90.0/90.0/90.0
crystal size (μm3) 40 × 100 × 200 40 × 100 × 200 75 × 75 × 200 100 × 100 × 200
Data Collection
X-ray source ESRF-ID29 ESRF-ID29 ESRF-ID29 SLS-PXII-X10SA
wavelength (Å) 0.9724 0.9724 0.9763 0.9999
ﬂux (photons/s) 1660 × 109 1600 × 109 75 × 109 225 × 109
beam size (μm2) 30 × 50 30 × 50 30 × 50 100 × 100
total exposure (s) 19 30 150 120
absorbed X-ray dose (MGy) 7.4 11.3 2.4 1.0
resolution range (Å) 47.0−1.9/2.0−1.9 47.0−2.1/2.2−2.1 62.5−2.1/2.2−2.1 53.7−1.8/1.9−1.8
temperature (K) 100 100 100 100
completeness (%)a 90.4/92.9 88.7/84.9 98.5/98.9 98.2/99.3
redundancya 2.1/2.1 2.8/2.7 3.9/3.9 4.1/4.1
I/σ(I)a 11.3/2.1 5.7/2.7 8.6/2.8 11.3/2.9
RSym
a,b 10.7/37.9 10.1/30.1 9.5/43.7 5.9/45.0
Reﬁnement Statistics
Rwork (%)
c 18.4 21.0 17.7 16.7
Rfree (%)
d 23.4 26.0 23.3 20.9
Model Content
amino acids 574 574 407 408
Fe ions (occupancy) - 4 (100%) 2 (90%) 2 (50%)
Mn ions (occupancy) 4(100,90,100,100%) - - -
Cl− ions - - 1 5
water molecules 166 61 117 196
FMN cofactors - - 1 1
molecules per asu 2 2 1 + 1 1 + 1
solvent content (%) 40.1 42.7 54.2 50.8
unmodelled residues 288−322 (both
monomers)
288−322 (both
monomers)
291−322 (NrdF), 117−119
(NrdI)
291−322 (NrdF), 118−119
(NrdI)
volume not occupied by model (%) 28.8 30.7 45.2 43.0
Model Analysis
mean overall isotropic B-factor (Å2) 19.8 19.5 32.9 32.1
Ramachandran plot: ratio in most favored/
other allowed regions/generously allowed
regions (%)
96.9/3.1/- 96.9/3.1/- 92.7/6.5/0.8 95.9/3.5/0.5
estimated overall coordinate error based on
Rwork/maximum likelihood (Å)
0.19/0.11 0.33/0.15 0.18/0.12 0.11/0.084
RMSD bonds (Å)/angles (deg) 0.019/1.90 0.017/1.78 0.019/2.04 0.020/1.90
PDB code 4BMU 4BMT 4BMP 4BMO
aThe value before the slash is for all data, and the value after the slash is for the data in the highest resolution shell. bRSym = Σ|I − ⟨I⟩|/ΣI
cRwork = Σ
(|Fo| − |Fc|)/Σ|Fo| dRfree is the Rwork calculated on the 5% reﬂections excluded for reﬁnement.
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structures, while the other major conformations (67%) bridge
both metals similar to the μ-1,3 coordination observed in the Ec
NrdI-MnII2-NrdF and Mn
II
2-NrdF structures (Figure 4B). This
opens up for a water coordinating to the Mn2 site and an
extended water network (as discussed below). The μ-1,3
coordination of this Glu residue was not reported for the Bs
MnII2-NrdF structure (PDB id: 4DR0)
33 and thereby not
supporting a direct Fe to Mn induced movement of Glu158 (Ec
numbering) as observed in Ec and now in Bc. However,
although Glu164 (Bs numbering) is reported to coordinate only
to Mn2 in a bidentate fashion, some negative density can be
seen in the diﬀerence map at the modeled Glu164, and some
positive density where an alternative conformation for Glu164
bridging both metals in a μ-1,3 fashion would be positioned,
supporting ﬂexibility at the Glu161 (Bc numbering) site. In the
Ec structures, the main-chain between Phe162 and Glu158 (Ec
numbering) has an altered conformation between the Fe and
Mn structures, while in the Bc structures, the main-chain
between Phe165 and Glu161 (Bc numbering) is more similar,
resulting in an incomplete μ-1,3 coordination of Glu161 in Bc
MnII2-NrdF (Supplementary Figure S3). The observed diﬀer-
ence could be due to the fact that the Ec structures are co-
crystallized with MnII, while the Bc crystals have been soaked
with MnII, thereby allowing less structural adjustments in Bc.
This further indicates that the Glu161 movement is linked to
the Mn substitution. The movement of Glu161 in Bc from a
Figure 3. Metal ion sites in Bc Fe2-NrdF and Mn
II
2-NrdF. (A and C) Monomer A in in Bc Fe2-NrdF, (B and D) monomer B in Bc Fe2-NrdF. (E and
G) Monomer A in Bc MnII2-NrdF and (F and H) monomer B in Bc Mn
II
2-NrdF. The Fe ions are shown as orange spheres, Mn ions as purple
spheres, and the coordinating amino acids and Tyr100 are represented as sticks and colored by atom type. The 2Fo − Fc electron density map (gray)
is contoured at 1σ and the Fo − Fc map is shown as green mesh (3σ) and red mesh (−3σ), whereas the omit map (salmon) surrounding the Fe or
Mn ions is contoured at 6σ (C, D, G and H). Glu161 coordinates to Fe2 in a bidentate fashion in monomer A and in a monodentate fashion in
monomer B of Fe2-NrdF (A−D). In Mn2-NrdF, two and three diﬀerent conformations are observed for Glu161 in monomers A and B, respectively,
varying between a bidentate mode coordinating to Mn2 alone and a conformation bridging both metals (E−H).
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bidentate coordination of metal site 2 to a μ-1,3 coordination is
further associated with a rotation of Phe165 (Figure 4A and
Supplementary Figure S3), which is also observed in Ec
between the FeII2-NrdF and Mn
II
2-NrdF/NrdI-Mn
II
2-NrdF
structures.25 Moreover, if the ﬂexibility of Glu161 in the Bc
MnII2-NrdF structures is inﬂuenced by a minor iron
contamination, as previously reported in work by Tomter et
al.,38 an inhomogeneous metalation in metal site 2 would even
stronger support a metal-type-dependent movement of Glu161.
The redox state and the pH of the metal ion cluster is also
known to inﬂuence the conformation of the coordinating
residues.6,39 The metal cluster environments in the two Bc apo-
NrdF structures are shown in Supplementary Figures S4 and
S5. The trends for Glu195 and Glu93 coordination seem more
unclear, while Glu161 coordination appears to give important
insight into the distinction between the Fe- and Mn-NrdF/
NrdI-NrdF structures (Figure 4A and B). In both Bc NrdI-Fe2-
NrdF complex crystals, Glu161 coordinates bidentate to iron
site 2 alone, opposite to what is seen in the Ec NrdI-MnII2-NrdF
structure, where the corresponding carboxylate ligand bridges
both metals in a μ-1,3 fashion (Figure 4B). It has been
proposed that the latter conformation allows greater access of a
manganese-bound water ligand, hydrogen-bonded to an
ordered water network facilitating oxidant transport from the
NrdI FMN cofactor.25 The μ-1,3 coordination of Glu161 is
observed in both the Ec MnII2-NrdF structure and the Bc Mn
II
2-
NrdF structure (major conformation in monomer A), the latter
presented here. The Bc MnII2-NrdF and Bc Fe2-NrdF structures
presented here are therefore important toward a more
generalized understanding of the metal-ion-dependent move-
ment of this Glu residue with respect to NrdF activation. These
observations support greater ﬂexibility of the residues
surrounding the class Ib NrdF metal sites and that variations
in the carboxylate conformations seem to be linked to the
metal-type present at the dimetal site, rather than induced by
NrdI binding to NrdF, as also supported by NrdI-NrdF binding
studies in Ba apo, Fe-, and Mn-NrdF.27
NrdI-NrdF Interface Solvent Channel. In the Ec and Bc
NrdI-NrdF complexes, the proposed solvent-accessible channel
extends from the vicinity of the metal site 2 in NrdF to the
FMN cofactor of NrdI (Figure 5). This channel is structurally
conserved in Bc and Ec NrdF with identical side-chain
geometries of the lining residues Ser157/154, Tyr166/163,
Ser162/159, Asn267/264, Lys263/260 and main-chain CO
for Glu195/192, Ser196/Ala193 (Bc/Ec numbering). In the
interface between NrdF and NrdI, the water network is slightly
altered, due to Tyr 197 in Ec replacing Val200 in Bc; however,
FMN is also slightly shifted. Unlike observed in the Ec MnII2-
NrdF structures with Glu158 in a μ-1,3 coordination, the
solvent channel modeled in the Bc NrdI-NrdF complex is
Figure 4. Overlay of metal sites in diﬀerent NrdF crystal structures. (A) Metal sites in the diﬀerent Bc NrdF crystal structures. (B) Metal sites in class
Ib β2 structures from diﬀerent organisms. The Mn ions and Fe ions are colored as purple and orange spheres, respectively, and the coordinating
amino acids, as well as Tyr100 and Phe165, are represented as sticks and colored by atom type. Structures compared in panel B (A chains) are; Bc
NrdI-Fe2-NrdF-1, Ec NrdI-Mn
II
2-NrdF complex (PDB id: 3N39),
25 Bc MnII2-NrdF, Ec Mn
II
2-NrdF (PDB id: 3N37),
25 Ec FeII2-NrdF (PDB id:
3N38),25 Bs MnII2-NrdF (PDB id: 4DR0),
33 Ca MnII2-NrdF (PDB id: 1KGP),
30 Ca FeII2-NrdF (PDB id: 1KGO),
30 Mt FeII2-NrdF (PDB id:
1UZR),32 and St FeII2-NrdF (PDB id: 1R2F).
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prevented from accessing the Fe2-NrdF site largely due to the
bidentate coordination mode of Glu161 to Fe2, blocking the
channel (Figure 5). Only in the case of the Ec NrdI-MnII2-NrdF
structure does Glu158 allow full access of the solvent channel
directly to the vicinity of the MnII2 site. A similar water network
is also seen around the Mn2 site in the Bc MnII2-NrdF structure
(Figure 3E and G). The NrdI-NrdF channel modeled for the Bc
complex, and compared to the Ec complex, is shown in Figure
5A and B, respectively. Diﬀerent Glu161 conformations
observed for the Ec NrdI-MnII2-NrdF and Bc NrdI-Fe2-NrdF
complex structures indicate that variations in the NrdF active
site geometries might be present during active cofactor
formation. The diﬀerent geometries are likely not aﬀected by
NrdI binding to NrdF in protein complex formation. Highly
similar NrdI-NrdF interfaces in both complexes are observed
(see below), regardless of metal ion bound in the NrdF active
site.
NrdF Interface with NrdI. The overall structure compar-
ison of Ec and Bc NrdI-NrdF shows that the overall interaction
between NrdF and NrdI is similar in the two organisms;
however, the binding of NrdI to NrdF in Bc is slightly rotated
compared to NrdI-NrdF binding in Ec (Supplementary Figure
S1). The amino acids lining the Bc and Ec NrdI-NrdF interface
show a high level of conservation. This is a general attribute for
all class Ib RNRs, supported by the high sequence similarity33
at the interface region, supporting invariable NrdI binding to
the NrdF surface for class Ib RNRs. The charged and polar
residues lining the NrdI-NrdF interface in both Ec and Bc
complex structures create a hydrophilic environment consistent
with channeling of a hydrophilic oxidant: H2O2 or O2•− for
generation of the active MnIII2-Y• cofactor in class Ib RNRs.
One variation between the two complex structures of NrdI-
NrdF in Bc and Ec is the distance between the NrdI ﬂavin plane
to the NrdF interface, which is 0.4 Å closer (based on whole
structure alignment as measured from N5 of FMN), for the Bc
structure, creating a narrower interface (Figure 1B). A
comparison of the Bc and Ec NrdI-NrdF structures, showing
an ordered and identical hydrogen bonding network between
conserved residues lining the core interface in both structures,
is shown in Figure 6A and B. This core interface is likely
essential for recognition between NrdFs and NrdIs in class Ib
RNRs. Frequently, proteins involved solely in electron transfer
do not interact in a well-deﬁned orientation,40 and therefore,
the observation of a conserved binding-core between NrdI and
NrdF supports that the complex is important for more than
pure electron transfer, as it also generates a channel for the
transfer of H2O2 or O2•−. Outside this core region, however,
residues in the protein interface are not conserved, probably
leading to a small rotation of NrdI relative to NrdF as observed
between the Bc and Ec NrdI-NrdF structures (Supplementary
Figure S1). While the core region governs recognition, amino
acid diﬀerences outside the core must be important for the
variations observed in NrdI-NrdF binding in Ec and the Bacillus
species, where the association is much stronger in Ec than in
Bacillus.18,22,27,28 The conserved core interface region on the
NrdF surface, as observed in the Bc and Ec NrdI-NrdF complex
structures, is not present in the class Ia R2/NrdB, as shown in
the structural alignment of the Bc NrdF and Ec NrdB
structures41 (Supplementary Figure S6). The structural diﬀer-
ences in NrdBs, compared to NrdFs, do not support binding to
NrdI, as observed in the class Ib NrdI-NrdF complex
structures.25 Moreover, the conserved class Ib NrdF interface
region is also absent in eukaryotic class Ia R2 structures, as
observed in mouse R239 and human p53R2.42
Spectroscopic Similarity between NrdI and NrdI-NrdF.
Single-crystal light absorption measurements performed on
crystals of Bc NrdI and Bc NrdI-NrdF show similar ﬂavin
spectra, indicating little or no inﬂuence on the NrdI FMN
cofactor upon NrdF binding. Figure 6C shows the spectra
obtained from the two crystals (Bc NrdI and Bc NrdI-NrdF)
both containing NrdI in its oxidized (NrdIox) form. The light
absorption spectrum of a crystal depends on crystal orientation
relative to the incident beam, causing small variations in the
shapes of diﬀerent peaks.43 High structural similarity is
Figure 5. NrdI-NrdF solvent channel. (A) The Bc NrdI-Fe2-NrdF
complex structures showing the hydrophilic channel connecting the
active site in Fe2-NrdF with the FMN cofactor in NrdI, calculated
using a 1.4 Å probe radius, and (B) structural alignment of the Bc and
Ec (PDB id: 3N39) NrdI-Fe2-NrdF and NrdI-Mn
II
2-NrdF complexes,
respectively, showing a closer view of the solvent channel (Bc; blue
mesh, Ec; cyan mesh) connecting the NrdF and NrdI cofactors. Bc
NrdI is shown as a yellow ribbon diagram and Bc Fe2-NrdF as a green
ribbon diagram, whereas the FMN cofactor in Bc NrdI and the
residues in the active site of Bc Fe2-NrdF are represented as sticks and
colored by atom type. The Ec structure is shown in gray. Fe ions are
shown as orange spheres (Bc), while MnII ions are shown as purple
spheres (Ec). The Glu161 conformation in the Bc structure occupies
the terminal part of the solvent channel, as modeled for the Ec
structure, preventing the solvent channel in Bc from accessing the Fe2-
NrdF site.
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observed between NrdI from the Bc NrdI-NrdF crystal complex
and Bc NrdI (PDB id: 2X2O)23 (RMSD calculated to 0.37 Å)
and between Fe2-NrdF and NrdF from the Bc NrdI-NrdF
crystal complex (RMSD calculated to 0.54 Å).
Investigation of the Possible NrdI-NrdF-NrdE Inter-
face. Given that NrdI is required for MnIII2-Y• cofactor
generation,24 it is important to gain information about how
NrdI-NrdF assembly eﬀects NrdF-NrdE holoenzyme forma-
tion. A model of the α2β2 holocomplex structure was ﬁrst
proposed by Uhlin and Eklund in 199414 for the class Ia RNR.
Complementarity was shown between the α2 (NrdA) dimer
and the upper part of the heart-shaped structure of the β2
(NrdB) dimer, and a model was constructed with the 2-fold
axes of the dimers superimposed. The proposed holoenzyme is
believed to form a compact complex, where the binding surface
of the NrdB dimer contains a region of high conservation.14 A
high extent of amino acid conservation in the corresponding
region has also been addressed for various class Ib NrdF
structures, through a sequence alignment study performed by
Boal et al.33 Also, high amino acid sequence conservation was
shown for the NrdI-NrdF interface. The Bc NrdI-NrdF
complex interface supports NrdI binding in the same general
location on all NrdFs, as suggested previously.33 In this study,
we report that binding of NrdI to NrdF can disturb the α2β2
holocomplex formation in class Ib RNRs, contrary to what was
previously suggested by Zhang et al.29 The NrdI-NrdF complex
assembly in Bc introduces steric clashes in the binding site
between α2 and β2 in the proposed holocomplex assembly,
possibly preventing the suggested holoenzyme complex
formation. A structural alignment of the Bc NrdI-NrdF
structure with the Ec α2β2 holoenzyme structure, generated
using the original class Ia α2β2 holocomplex coordinates, is
shown in Figure 7. The two aligned dimeric class Ia and Ib R2
structures share a structural homology with an RMSD of 2.6 Å.
These ﬁndings could possibly indicate the role of a diﬀerent
holocomplex interaction for the class Ib RNRs, which, contrary
to the class Ia RNRs, require an additional binding partner,
NrdI, for MnIII2-Y• cofactor assembly. However, recent studies
of Ec RNR support the active prokaryotic form of the enzyme
with an α2β2 stoichiometry.
15,44 Conversely, another likely
possibility supporting the α2β2 holoenzyme structure by Uhlin
and Eklund is that the activation of the MnIII2-Y• cofactor
occurs in an initial stage prior to R1-R2 interaction in the α2β2
complex. This would result in NrdI dissociation prior to α2β2
holoenzyme formation, thereby preventing structural clashes
between the respective binding partners. The structural
requirement of NrdI dissociation prior to NrdE binding to
NrdF could be supported by, as well as further explain, previous
Figure 6. NrdI-NrdF protein−protein interface and single-crystal light absorption spectra. Comparison of the conserved hydrogen bonding network
in the NrdI-NrdF core interface in the (A) Bc and (B) Ec (PDB id: 3N39) NrdI-NrdF crystal structures. NrdF residues are colored green, while NrdI
residues are colored yellow. (C) Single-crystal light absorption spectra of Bc NrdI (dashed) and NrdI-NrdF (solid). Typical features of the oxidized
state of the ﬂavin cofactor are observed for the NrdIox crystal and similar features are in the NrdI-NrdF crystal, regardless of the interaction with
NrdF. A weaker signal is observed for the NrdI spectrum, largely due to crystal thickness.
Figure 7. Ec class Ia α2β2 holoenzyme complex. The holoenzyme complex, shown from two diﬀerent views (A and B), was generated by alignment of
the R2 dimer (β2) with the R1 dimer (α2),
14 overlaid with the class Ib Bc NrdI-Fe2-NrdF complex. NrdI protrudes into the α2β2 interface, interfering
with binding to the R1 dimer.
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activity and binding studies in Ec, Bc, and Ba. In Ec, a tight
association between NrdI and NrdF has been reported,18 and if
NrdI needs to dissociate before NrdE can bind, this could
explain the observed lower RNR speciﬁc activity of Fe-NrdF-
NrdE in the presence of NrdI, resulting in an inhibitory eﬀect,
compared to a 4-fold higher speciﬁc activity in the absence of
NrdI.18 In contrast, in the case of Bacillus species, where the
interaction between NrdF and NrdI has been shown to be
weak,22,27 NrdI does not inhibit FeIII2-Y• cofactor generation
(in Ba and Bc)28 or RNR enzymatic activity (in Ba27 and Bc28),
indicating that the weaker NrdI-NrdF association in Ba and Bc
makes NrdF more accessible for NrdE binding. Additionally,
the removal of NrdI after activation of Mn-NrdF by NrdI does
not increase speciﬁc activity in Ba and Bc or inﬂuence the
binding of NrdH-thioredoxin to NrdE.27 However, this type of
investigation has not been reported for the Ec Mn-containing
RNR, which might result in higher in vitro speciﬁc activity
proceeding from NrdI removal, as a result of NrdI’s tight
association with NrdF. The α2β2 holoenzyme model by Uhlin
and Eklund could then be valid also for class Ib. Whether the
diﬀerences between Ec and Bacillus species could be related to
the presence of the additional class Ia RNR in Ec should be
further investigated. The conserved NrdI binding to NrdF
could be of great importance in the development of
antimicrobial drugs, depending on the organisms degree of
NrdI-NrdF aﬃnity. Moreover, an alteration in the NrdF
interface responsible for binding of NrdI as well as NrdE could
strongly aﬀect active class Ib RNR activation and holoenzyme
assembly. An overlay of Bc NrdI-NrdF with the St R1-R2
crystallographic complex from Uppsten et al.45 also results in
some clashes (Supplementary Figure S7A). In contrast, an
overlay of the Bc NrdI-NrdF structure and the inactive α4β4 Ec
structure46 gives no structural clashes between NrdI and NrdB
(Supplementary Figure S7B). Moreover, additional studies for
investigation of class Ib RNR interactions and active
holoenzyme formation are still required.
Conclusion. The Bc NrdI-NrdF complex structure
presented in this paper strongly resembles the previously
solved NrdI-NrdF complex from Ec,25 showing only small
variations in NrdI binding to NrdF in class Ib RNRs. The
ﬂexibility in key coordinating residues of the dimetal sites in Bc
NrdI-NrdF and NrdF structures supports the suggestion that
diﬀerent active site geometries can serve as starting points for
metallocofactor activation. However, Glu161 (Bc numbering)
seems to be a key residue in distinguishing between the Fe and
Mn activated structures. The higher tendency of Glu161 for a
μ-1,3 coordination in Mn structures, as now seen in both Ec
and Bc, in contrast to the bidentate coordination seen in Fe
structures, opens up for a water network through the proposed
and highly conserved hydrophilic channel leading to the FMN
site in NrdI. The channel and water network is blocked in the
Bc NrdI-Fe2-NrdF and Fe2-NrdF structures through the
bidentate coordination of Glu161 to metal site 2. The high
degree of amino acid sequence conservation of core residues in
the NrdI-NrdF interface supports similar NrdI-NrdF recog-
nition in all class Ib RNRs, as indicated by the same general
binding location in the crystal structures of NrdI-NrdF
complexes in Bc, Ec,25 and the modeled Bs NrdI-NrdF
complex.33 Since binding of NrdI to NrdF also occurs for
Fe2-NrdF, not requiring NrdI for activation, the presence of Mn
is not a requirement for NrdI binding. This is supported by the
Bc NrdI-NrdF complex structure, crystallized with an Fe2 site
contrary to the Ec NrdI-MnII2-NrdF crystal structure, which is
the MnII2-containing active complex. Also, NrdI-NrdF binding
seems to be conserved regardless of the structure of the metal
coordination site, where diﬀerent carboxylate conformations are
observed for diﬀerent crystal structures. Steric clashes
introduced by NrdI in the NrdI-NrdF-NrdE formation
presented in this study could indicate a requirement for NrdI
to dissociate before NrdE can bind to NrdF; however, further
investigation of the mechanism of class Ib active holoenzyme
formation is required.
■ METHODS
Cloning, Expression, and Puriﬁcation of Bc NrdF and NrdI.
Bc ATCC 14579 NrdF (BC1355) and NrdI (BC1353) were expressed
and puriﬁed as described previously.23,38 In brief, genes were cloned
into the pET-22b plasmid (Novagen) prior to transformation into
competent Ec BL21 (DE3) Gold cells (Stratagene). Cells containing
the pET-22b-NrdF or -NrdI were grown in Terriﬁc Broth medium
containing 100 μg/mL ampicillin. Protein expression was induced by
adding isopropyl β-D-1-thiogalactopyranoside to a ﬁnal concentration
of 0.8 mM, and the culture was incubated for 12−16 h at 20 °C with
vigorous shaking before harvesting. The frozen cell paste was lysed
using an X-press,47 dissolved in 100 mM Tris-HCl, pH 7.5, 10 mM
EDTA, and cleared from nucleic acids by streptomycin sulfate (2.5%)
precipitation. Proteins were precipitated with 60% ammonium sulfate
(0.43 mg/mL), dissolved in 50 mM Tris-HCl, pH 7.5, and desalted
using a HiTrap Desalting column (GE Healthcare). Desalted protein
was applied to a HiTrap HP Q column (GE Healthcare), and the
proteins were separated with a 0−0.5 M KCl gradient. As a ﬁnal
polishing step, the proteins were puriﬁed on a Superdex 200 column
(GE Healthcare).
Crystallization. All initial crystallization screening was performed
with an Orxy6 crystallization robot (Douglas Instruments Ltd.).
Crystallization of the Bc NrdI-NrdF Complex. For the NrdI-
NrdF complex, NrdF (monomer) and NrdI (both in 50 mM Tris-HCl,
pH 7.5) were mixed in an equimolar amount. Bright yellow crystals
(20 mg/mL total protein) were obtained using the sitting drop vapor
diﬀusion method at RT with 10% (w/v) PEG 8000, 0.2 M magnesium
chloride, and 0.1 M Tris, pH 7.0 (JCSG-plus Screen, Molecular
Dimensions Ltd.). Crystals were brieﬂy soaked in cryoprotectant
solution (25% glycerol, 10% (w/v) PEG 8000, 0.2 M magnesium
chloride, and 0.1 M Tris, pH 7.0) and ﬂash frozen in liquid nitrogen
(NrdI-NrdF-1). Yellow crystals (5 mg/mL total protein) were also
obtained using the same method with 2 M sodium chloride and 0.1 M
sodium citrate, pH 6.0 (ProPlex Screen, Molecular Dimensions Ltd.),
soaked in cryoprotectant solution (25% PEG 400, 2 M sodium
chloride, and 0.1 M sodium citrate, pH 6.0) and ﬂash frozen in liquid
nitrogen (NrdI-NrdF-2). The NrdI-NrdF crystals were not soaked in
metal solutions before collecting X-ray data; however, the medium
used for expression of the genes naturally contains traces of iron.
Crystallization of Bc NrdFs. Fe2-NrdF and Mn
II
2-NrdF crystals (8
mg/mL monomer) were obtained with 0.2 M Mg-formate, 20% (w/v)
PEG 3350, and 0.1 M HEPES, pH 7.5 (optimized from the JCSG-plus
Screen, Molecular Dimensions Ltd.) and soaked for 20 min in
cryoprotectant solution containing the mother liquor mixed with 25%
PEG 400 and Fe(NH4)2(SO4)2/sulfuric acid or MnCl2, respectively.
Also, two apo-NrdF structures have been solved from crystals obtained
with 0.04 M H3PO4, 16% PEG 8000, and 20% glycerol (apo-NrdF-1),
and with 0.2 M Mg-formate pH 5.9 and 20% PEG 3350 (apo-NrdF-2)
(JCSG-plus Screen, Molecular Dimensions Ltd.), both soaked in
cryoprotectant solution containing the mother liquor including 30%
glycerol. Finally, all NrdF crystals were ﬂash frozen in liquid nitrogen.
Data Collection and Reﬁnement. Crystallographic data sets
were collected at beamlines ID29 and ID14-1 at the European
Synchrotron Radiation Facility (ESRF), Grenoble, France and at PXII-
X10SA at the Swiss Light Source (SLS) at Paul Scherrer Institut,
Villigen, Switzerland. The crystallographic data for NrdI-NrdF-1, as
well as Fe2-NrdF and Mn
II
2-NrdF, were collected at ID29 (ESRF), the
apo-NrdF-1 and apo-NrdF-2 at ID14-1 (ESRF), and the NrdI-NrdF-2
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at X10SA (SLS). Data sets were processed with MOSFLM48 and
scaled and merged using SCALA or AIMLESS,49,50 and the space
group was conﬁrmed with POINTLESS through the CCP4 software
suite.51 The structures were solved by molecular replacement using
PHASER.52 A homologue model of Bc apo-NrdF modeled with
SWISS-MODEL53,54 from the Ca apo-R2 structure (PDB id: 3DHZ)42
was used as a search model in PHASER to solve the Bc apo-NrdF-1
structure. The Bc apo-NrdF-1 was then used as a search model to solve
the structure of apo-NrdF-2, Fe2-NrdF, and Mn
II
2-NrdF. The NrdI-
NrdF-1 structure was solved with the coordinates of Bc apo-NrdF-1
and Bc NrdI (PDB id: 2X2O) as the starting models. Reﬁnement for
all structures was done using restrained reﬁnement in REFMAC,55 and
model building was performed with COOT56 in multiple cycles. For
the Bc NrdF structures, medium NCS restraints were introduced. For
some of the structures, full occupancy of the metal sites gave negative
density in the diﬀerence maps, and for these structures the metal
content was reduced. NrdI-NrdF-1 has been reﬁned with 90% Fe,
NrdI-NrdF-2 with 50% Fe, MnII2-NrdF with one site 90% while the
remaining 100% Mn, and Fe2-NrdF with 100% Fe with high B-factors.
For the apo structures, one of the metal sites 1 in apo-NrdF-1 and two
metal sites 1 in apo-NrdF-2 have been modeled with 25% occupancy
of Fe. The absorbed X-ray doses of the diﬀerent crystals during
crystallographic data collection have been calculated with the program
RADDOSE.57,58 All structure ﬁgures were prepared using PyMOL.59
All backbone root-mean-square deviation (RMSD) values were
calculated using PDBeFold (http://www.ebi.ac.uk). The ﬁnal data
collection and reﬁnement statistics are listed in Table 1 and
Supplementary Table S1. The hydrophilic complex channel lining
the Bc NrdI-NrdF interface was calculated with HOLLOW60 using a
1.4 Å probe radius. As a comparison, a corresponding channel was also
calculated for the Ec NrdI-NrdF structure.25
Single-Crystal Light Absorption Spectroscopy. Light absorp-
tion spectroscopy was carried out on single crystals (frozen as
described above) of Bc NrdI and Bc NrdI-NrdF. The experiments were
performed at beamline X10SA and SLSpectroLAB at SLS. Spectra
were recorded with an on-axis built microspectrophotometer system
with an Andor 303i Czerny−Turner spectrograph and a Newton
electron multiplying CCD (Andor Technology).61
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FIGURE S1. Overlay of Bc and Ec NrdI-NrdF crystal structures, based on structural alignment of  
the NrdIs. The overlays are shown in different orientations (A and B). A small rotation is observed 
for the NrdF subunit for the Bc structure as compared to the Ec structure (PDBid:3N39) 1, when the 
two NrdI subunits are kept aligned, indicating a rotational difference in the NrdI-NrdF binding in the 
two crystal structures. 
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FIGURE S2. The overall crystal structures of Bc NrdFs. (A) Overlay of all NrdF structures. (B) 13 
additional residues of the flexible C-terminal in monomer A of apo-NrdF-1 are visible in the electron 
density map, due to different crystal packing. (C) and (D) displays the crystal surface corresponding 
to residues 25-30, where NrdI-Fe2-NrdF-1 shows greater helical conformation compared to the other 
NrdF structures. The same helical conformation is also observed in monomer B of apo-NrdF-1 (D).  
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FIGURE S3. Loop alteration in the di-metal cluster vicinity in NrdF. Possible limitation in 
movement from  bidentate to μ-1,3 coordination of Glu 161 (Bc numbering) in the di-manganese 
soaked Bc MnII2-NrdF crystal structure, compared to co-crystallized Ec MnII2-NrdF crystal structure 
of NrdF (PDBid:3N37) 1, due to the restricted loop flexibility. 
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FIGURE S4. Active site environment in the Bc apo-NrdF-1 structure. (A) and (C) shows monomer 
A, while (B) and (D) shows monomer B. Amino acids are represented as sticks and colored by atom 
type. In monomer A, metal site 1 is modeled with 25% iron occupancy, whereas no metal occupancy 
is observed for the second metal site (A and C). No metal occupancy is observed in monomer B (B 
and D). The 2Fo-Fc electron density maps (grey) are contoured at 1ı, the Fo-Fc map is shown as green 
mesh (3ı) and red mesh (-3ı), while the omit map (salmon) surrounding the Fe  ions is contoured at 
6ı.  
 
 
 
 
 
 
 
 
 
 
 
8

 
FIGURE S5. Active site environment in the Bc apo-NrdF-2 structure. (A) and (C) shows monomer 
A, while (B) and (D) shows monomer B. Amino acids are represented as sticks and colored by atom 
type. Metal site 1 in both monomers A (A and C) and B (B and D) have been modeled with 25% iron 
occupancy. The 2Fo-Fc electron density maps (grey) are contoured at 1ı, the Fo-Fc map is shown as 
green mesh (3ı) and red mesh (-3ı), while the omit map (salmon) surrounding the Fe  ions is 
contoured at 6ı.  
 
 
 
 
 
 
 
 
 
 
 
9

 
Fig. S6. Residues on the surface of the class Ib Bc R2F/NrdF (from NrdI-NrdF) and class Ia Ec 
R2/NrdB (PDBid:1RIB) 2, showing differences in the core residues shown to be involved in the 
conserved hydrogen bonding network in the NrdI-NrdF core interface in the class Ib RNR. 
10

FIGURE S7. The Bc NrdI-Fe2-NrdF complex overlaid with different RNR complexes. (A) The Bc 
NrdI-Fe2-NrdF overlaid with St class Ib crystallographic R1-R2 holoenzyme complex (PDBid:2BQ1) 
3, and (B) with the Ec class Ia D4E4 ring-like structure (PDBid:3UUS) 4, 5.  
 
11
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Abstract
Thioredoxin-like proteins contain a characteristic C-x-x-C active site motif and are involved in a large number of biological
processes ranging from electron transfer, cellular redox level maintenance, and regulation of cellular processes. The
mechanism for deprotonation of the buried C-terminal active site cysteine in thioredoxin, necessary for dissociation of the
mixed-disulfide intermediate that occurs under thiol/disulfide mediated electron transfer, is not well understood for all
thioredoxin superfamily members. Here we have characterized a 8.7 kD thioredoxin (BC3987) from Bacillus cereus that unlike
the typical thioredoxin appears to use the conserved Thr8 side chain near the unusual C-P-P-C active site to increase
enzymatic activity by forming a hydrogen bond to the buried cysteine. Our hypothesis is based on biochemical assays and
thiolate pKa titrations where the wild type and T8A mutant are compared, phylogenetic analysis of related thioredoxins, and
QM/MM calculations with the BC3987 crystal structure as a precursor for modeling of reduced active sites. We suggest that
our model applies to other thioredoxin subclasses with similar active site arrangements.
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Introduction
Thioredoxin (Trx) and glutaredoxin (Grx) are small ubiquitous
proteins acting as cysteine disulfide oxidoreductases in the cell and
belong to the thioredoxin superfamily [1–3]. Within this family
several classes of proteins have been characterized [4]. They are
involved in enzymatic reactions as hydrogen donors [5,6], in redox
signaling [7], protein folding [8], and in the defence against
oxidative stress [9]. In general, the Trx-like proteins are reduced
by NAD(P)H dependent thioredoxin reductases (TrxR) and they
usually have a C-G-P-C active site motif. Grx-like proteins
typically contain a C-P-Y-C motif and are reduced by the
tripeptide glutathione formed by NADPH utilizing glutathione
reductases.
The fundamental mechanism for electron transfer from Trx to
its substrate was proposed by Kallis and Holmgren in 1980 [10].
As a result of the lowered pKa value they observed for the N-
terminal cysteine thiol (2SH) in the Escherichia coli Trx C-G-P-C
motif, it was suggested that this thiolate (2S2) could perform the
initial nucleophilic attack on the substrate disulfide bond. To make
the second nucleophilic attack, which dissociates the mixed
disulfide intermediate, it was stated that a deprotonation of the
buried C-terminal cysteine is necessary. However, the details of
this reaction were not discussed. In the following years a number
of studies have been focused on the active site thiols and the
mechanism behind the proton abstraction from the C-terminal
cysteine. It has been suggested that the helix macrodipole [11] or
microdipoles [12] are major determinants of Trx cysteine pKa
values, however, these explanations have been challenged in later
studies [13]. The largest contributions to shifts in pKa values are
believed to be intra-protein charge-charge interactions [14],
desolvation effects [15], and hydrogen bonding to the deproto-
nated thiol [16]. A recent study points at the latter effect as the
most important [17]. The thiolate form of the N-terminal
nucleophilic cysteine positioned at the end of an a-helix, as in
Trx, is suggested to be stabilized by intra-protein hydrogen
bonding to protein backbone amide protons resulting in a lowered
pKa value [18]. Most studies indicate that the buried C-terminal
cysteine pKa value is around or higher than ,8 [10,19–21], thus
an explanation for the proton abstraction for this residue is
required. A mechanism involving the highly conserved Asp26 and
a water molecule functioning as an acid/base catalyst for the
buried cysteine has been proposed for E. coli and Acetobacter aceti
Trx [22,23], however, this mechanism is still debated [24,25].
Interestingly, other sub-classes of the Trx superfamily with Trx
functionality do not have conserved acidic amino acids analogous
to the E. coli Trx Asp26. Examples are NrdH-redoxins that reduce
the active site of the catalytic subunit NrdE of the bacterial class Ib
ribonucleotide reductase (RNR) [26–28] and Clostridium pasteur-
ianum Cp9-type thioredoxins that reduce peroxiredoxins (Prx) [29].
The small thioredoxin BC3987 from Bacillus cereus having a
significant amino acid sequence similarity with both NrdH and
Cp9-redoxins can reduce class Ib RNR in both B. cereus and B.
anthracis [30]. However, the most efficient and likely in vivo class Ib
RNR reductant in those species is TrxA [31].
Here, we discuss how intramolecular hydrogen bonds can affect
deprotonation of the active site cysteines. Substituting the
conserved Thr8 that is close to the active site with Ala has altered
the hydrogen bond network and the effect of this has been
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characterized. We have also performed a phylogenetic analysis
comparing the amino acid sequence of BC3987 to homologs
collected from a range of bacterial species to elucidate which
amino acid(s) that contribute to the perturbation of the C-terminal
buried cysteine pKa value. The crystal structure of oxidized
BC3987 was solved and we have related the results from the
phylogenetic analysis to structural features, enabling us to map
parts of the protein involved in hydrogen bonds near the active
site. Finally, because no structure of reduced BC3987 was
obtained, we have modeled the reduced active site using quantum
mechanical/molecular mechanical (QM/MM) calculations and
rationalized the experimentally observed and unusually low pKa
value of the C-terminal buried cysteine through hydrogen bonding
to the conserved Thr8 residue. Based on these results, we suggest a
general reaction mechanism for the BC3987-like category of
thioredoxins.
Experimental
Cloning, Mutagenesis, Expression, and Purification of
BC3987
Genomic DNA was isolated from Bacillus cereus ATCC 14579
using the DNEasy kit from Qiagen. The coding sequence of
BC3987 including restriction sites for XbaI and HindIII was
amplified by PCR using the forward primer 59-CCCTCTA-
GAAATAATTTTGTTTAACTTTAAGAAGGAGATATACA-
TATGAAAAAAATTGAGGTTTAT-3 and backward primer
59-AGGAAGCTTAAAAGTTATTCTATATTGAGTAGTTG-
39. The gene was cloned into the pET-22b plasmid (Novagen)
and transformed into competent BL21 (DE3) Gold cells
(Stratagene). The T8A mutation of BC3987 was generated with
the primer 59-GAAAAAAATTGAGGTTTATGCACAACCC-
GATTGTCCGCC-39 using the QuikChange Site-Directed
Mutagenesis Kit from Stratagene. A 5 mL overnight culture of
BC3987 expressing cells was diluted 1:200 in 1 litre Terrific
Broth medium containing 100 mg/mL ampenicillin and grown
until O.D. 600 nm=0.7–0.8 at 37uC. The cultures were cooled on
ice until the temperature reached 15uC and then induced by
adding IPTG to a final concentration of 1 mM and the left for
15–16 hours at 20uC in a shaker before harvesting.
Approximately 30 grams of bacteria containing BC3987 was
lysed utilizing an X-press [32] and dissolved in 100 mL 100 mM
Tris/HCl pH 7.5 containing 10 mM EDTA before centrifuga-
tion. DNA was precipitated by adding streptomycin sulfate to a
final concentration of 2.5% (w/v). BC3987 was precipitated with
60% ammonium sulfate (0.43 mg/mL). Precipitated protein was
dissolved in 50 mM Tris/HCl pH 7.5 and desalted using a
HiTrap Desalting column (GE Healthcare). The desalted protein
solution was applied to a 1 mL Resource Q anion exchange
column (GE Healtcare) and the BC3987 was eluted using a 20 mL
0–400 mM KCl, 50 mM Tris/HCl pH 7.5, gradient. As a final
polishing step the protein was purified using a Superdex 200
column (GE Healtcare).
Protein Analysis and Concentration Determination
The homogeneity of the proteins was analyzed using a Superdex
200 gel filtration column and by SDS gel electrophoresis utilizing
the PhastSystem (GE Healtcare) equipped with an 8–25%
gradient gel. Protein purity was estimated to .95% by visual
inspection of gels. The extinction coefficient of BC3987 was
determined using the Edelhoch method [33], yielding a value of
eBC3987, 280 nm=8200 M21cm21.
Insulin Reduction Assay
The thioredoxin catalyzed reduction of insulin by dithiothreitol
(DTT) probes the efficiency of Trx - insulin reduction mechanism.
First, both proteins were incubated with 10 mM DTT for 30
minutes and then passed through a HiTrap Desalting column
equilibrated with 100 mM potassium phosphate buffer pH 6.5,
2 mM EDTA. The experiments was carried out in 96-well
microtiter plates containing 160 mM insulin, 100 mM potassium
phosphate buffer pH 6.5, 2 mM EDTA, 1 mM DTT, and 10 mM
wt or T8A BC3987 [34]. A Tecan Sunrise plate reader was used to
monitor light scattering at 580 nm turbid solution of reduced
insulin.
Estimation of Active Site Cysteine pKa Values
To estimate the pKa values of the active site cysteines the
absorbance of the thiolate anion at 240 nm was followed during a
pH titration [35–37]. To prepare the reduced wt and T8A mutant
BC3987 protein and their corresponding oxidized references, the
proteins were incubated with 200 mM DTT or 100 mM diamide
for 1 hour, respectively. Excess DTT and diamide was removed
using a HiTrap Desalting column (GE Healthcare) equilibrated
with a polybuffer with pH 9.3 consisting of 1 mM of each sodium
phosphate, sodium citrate, sodium borate, and 0.1 mM EDTA.
Spectra of 10–25 mM oxidized and reduced BC3987 was recorded
with a HP 8452 diode array spectrophotometer between 200 and
600 nm and corrected for the absorbance difference between the
two cuvettes, base line drift, and finally the 240 nm absorbance
values were normalized against the 280 nm values. The pH was
varied from 9.3 to 2.8 by adding 2–4 ml of 25 mM HCl and
measured using a PHM240 pH meter (Radiometer Analytical)
equipped with a PHC 4000-8 pH electrode. The equation e240
nm=A0+ A1/(1+10x2pKa1)+A2/(1+10x2pKa2) was used to estimate
the pKa values by fitting the curves in Figure 1.
Figure 1. Estimation of active site cysteines pKa values in wild
type and mutant BC3987. The pKa values of the active site cysteines
in BC3987 were estimated by pH titration resulting in pKa values 5.1 and
7.2 for the wild type and 7.2 for the T8A mutant. A cuvette containing
25 mM reduced protein in 1 mM polybuffer pH 9.3 was added 2 uL
aliquots of 25 mM HCl and the change in thiolate absorption at 240 nm
were followed with a UV-vis spectrometer.
doi:10.1371/journal.pone.0069411.g001
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Phylogenetic Analysis
The NrdH amino acid sequences collected from different
bacterial divisions were obtained from the Integrated Microbial
Genomes (IMG) website [38]. All the NrdH-redoxin amino acid
sequences contain the C-[IMV]-Q-C motif and are located in a
class Ib RNR operon. Sequences homologous to the Cp9-redoxin
found in the anaerobe C. pasteurianum, often annotated as YruB
proteins after its initial discovery [39], encoding proteins in the
range of 75–80 amino acids were downloaded from the UniProt
Knowledgebase [40]. Multiple sequence alignment was performed
by MAFFT [41] before manual editing using GeneDoc 2.7
(Nicholas and Nicholas, NRBSC). Columns containing gaps and
amino acids in the ranges 1–6 and 80–87 in the alignment (Figure
S1) were excluded from the phylogenetic analysis. The program
Treefinder [42] was used to estimate the substitution model and
reconstruct a bootstrapped phylogenetic tree with 1000 replicates
at a 50% consensus level utilizing the Maximum Likelihood (ML)
algorithm. A second bootstrapped phylogenetic analysis was
performed using the Neighbour Joining algorithm included in
ClustalX 2.0 [43] using 1000 replicates.
Crystallization of BC3987
Plate formed crystals were obtained with the Index screen
(Hampton Research, CA, USA) condition 55, at room tempera-
ture. BC3987 (18 mg/mL) in 15 mM Tris/HCl pH 7.5 was
mixed 1:1 with reservoir solution (0.1 M HEPES pH 7.5, 50 mM
MgCl2, and 30% (w/v) polyethylene glycol monomethyl ether
550). Crystals of approximately 4006400630 mm3 appeared after
1–2 days. Crystals of mutant BC3987 were obtained at the same
conditions as the wild type. So far, crystals with reduced active
sites motif have not been obtained when soaking with reductants
as DTT and sodium dithionite.
X-ray Data Collection
Data were collected at the Swiss-Norwegian Beam Line (SNBL,
BM01 A) and ID29 at the European Synchrotron Radiation
Facility (ESRF), Grenoble, France at 110 K. The protein crystals
were flash frozen after 30 seconds incubation in a cryo solution
consisting of PEG 400 and reservoir solution in a 1:6 ratio. The
crystals belong to the monoclinic P21 space group and have two
protein molecules in the asymmetric unit. Data were integrated
with iMOSFLM [44] before scaling and merging with SCALA
[45].
Structure Determination and Refinement
The program PHASER [45,46] was used to solve the structure
of the wild type protein by molecular replacement using a
polylalanine search model generated from the Corynebacterium
ammoniagenes NrdH protein structure [47], PDB ID 1R7H, which
has 32% amino acid sequence identity with BC3987. Two rounds
of simulated annealing with CNS [48] were followed by several
cycles of model building using COOT [49], ARP/wARP [50],
and structure refinement in REFMAC5 [51]. The mutant BC3987
crystal structures were solved using the wild type structure as start
model. The figures were prepared with PyMOL (W. L. DeLano
(2002) PyMOL, DeLano Scientific, San Carlos, CA). The atomic
coordinates and structure factors have been deposited in the
Protein Data Bank, Research Collaboratory for Structural
Bioinformatics, Rutgers University, New Brunswick, NJ.
QM/MM Calculations Modeling the Reduced Structure
In order to model the reduced active site of BC3987 two-layer
ONIOM [52] calculations were performed. The ONIOM
procedure allows part of the protein to be treated by quantum
mechanical (QM) methods (the high level layer) while a force field
based on classical mechanics (MM) is used to describe the rest of
the protein (the low level layer). All calculations were executed
through the Bioportal (www.bioportal.uio.no) using Gaussian 03,
Revision D.02 [53], at TITAN, the computing facility at the
University of Oslo. The crystal structure of BC3987 was used as a
starting point for modeling the reduced active site. All water
molecules were deleted from the structure and hydrogen atoms
were added using GaussView 4.1 (Gaussian, Inc.). The protonated
structure was then solvated by adding a 6 A˚ layer of TIP3P water
molecules using the Amber tools 1.2 package [54] and subjected to
geometry optimization. In this model preparation step, the
coordinates of protein hydrogen atoms and water molecules were
geometry optimized using the Amber force field as implemented in
Gaussian 03 while keeping the non-hydrogen protein atoms
frozen.
In the resulting structure the dihedral angles of Cys12 and
Cys15 defined by the atoms N-Ca-Cb-Sc were changed by 9u and
46u, respectively, increasing the distance between the two Sc atoms
from 2.14 to 3.63 A˚. The geometry optimized version of this
altered structure is from now on referred to as Model I. The
precursor of Model II has an additional modification, the
dihedral angle N-Ca-Cb-Oc of Thr8 was changed from 68.9 to
160u, making it resemble the Thr rotamer observed in E. coli
NrdH (PDBid:1H75 ) [55] and C. ammoniagenes NrdH
(PDBid:1R7H) [47].
Both models were geometry optimized at the ONIOM(R-
B3LYP/6-31+G(d,p):UFF) level using the charge equilibrium
(QEq) method [56] to assign atomic partial charges. During these
calculations, both Cys12 and Cys15 were in their thiolate forms.
The high level layer included Tyr7(C) – Gln9(Ca), the Cys12 side
chain, Pro14(C) - Cys15 Ca, including Cys15 HCa and side chain,
and the Thr53 side chain. All atoms in the high level layer were
allowed to move while the coordinates of protein atoms in the low
level layer, except Cys12 HCa, Ca, C, and O and Cys15 C and O,
were kept frozen during geometry optimization. The water
molecules within a radius of 15 A˚ of the Cys12 Sc-atom were
also allowed to move.
Results
Characterization of the C-P-P-C Active Site Cysteine pKa
Values
Different subclasses of the thioredoxin superfamily have
nucleophilic cysteine pKa values that correspond to their biological
function. Thus, this is an important parameter when classifying
new member of this superfamily.
When estimating the pKa values of the active site cysteines in
wild type BC3987 and the T8A mutant, DTT reduced samples
were compared with diamide oxidized references. A plot of the
thiolate extinction coefficient values plotted against the measured
pH is shown in Figure 1. Interestingly, it was observed that the
extinction coefficient difference at 240 nm (De240 nm) due to the
thiolate anion was 7–8000 M21cm21. This was a surprising result
as an expected De240 nm value of about 3500–4000 M
21cm21 is
typical for a single thiolate [57–59]. One possible explanation for
this observation is that both cysteines in the reduced C-P-P-C
active site have lowered pKa values. The pH-titration curves for
wild type and T8A BC3987 in Figure 1 are similar in the pH
interval 6.5–9, indicating that the nucleophilic Cys12 pKa value is
not affected by the T8A mutation. However, in the pH range 6.5–
3 there are clear differences. First, the T8A mutant is not stable
below pH 5.4 and precipitates. Second, the wild type curve has a
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shoulder between pH 4 and 6.5, indicating a titratable thiolate
with a lowered De240 nm. A lowered De240 nm for the buried Cys15
can be rationalized because the absorbance maximum of thiolates
depends on the polarity of the solution, shifting to lower
wavelengths with decreasing polarity. Following the reasoning
above, the wild type BC3987 has two titratable thiolates with pKa
values 5.1 and 7.2 while the T8A mutant has one thiolate with a
pKa value of 7.2 and a second thiolate that behave different from
the wild type.
BC3987 Wild Type and the T8A Mutant Reduction of
Insulin Disulfides
In the insulin reduction assay, thioredoxin catalyze the
reduction of insulin by DTT and the light scattering of reduced
insulin is measured. As shown in Figure 2, the control reaction
with insulin and DTT is very slow compared to the wild type and
T8A mutant BC3987 catalyzed reactions. The efficiency of
thioredoxin insulin reduction is measured in this assay, and from
the curves in Figure 2 it can be concluded that the wild type
BC3987 has a different reactivity towards the substrate compared
to the T8A mutant. The lag-time before any precipitated insulin is
observed is much longer for the T8A mutant, and the slope of the
curve after the lag-period is slightly steeper for the wild type
enzyme.
Phylogenetic Analysis
The BC3987 homologs within the B. cereus group have 28–32%
sequence identity to NrdH-redoxins and 37% sequence identity to
the Clostridium novyi Cp9-redoxin homolog. Thus, it was of interest
to compare these three groups that all belong to the thioredoxin
superfamily. The analysis was performed using the method of
Maximum Likelihood with a WAG [60] substitution model, based
on the AICc criterion [61,62] with optimized frequencies,
proposed by the Treefinder program. In the phylogenetic tree
shown in Figure 3, a node separates the three groups at a 94%
consensus level. The tip-to-tip distances between the node and the
three groups, Bacillus cereus group BC3987 homologs (Blue), Cp9
homologs (Green), and NrdH-redoxins (Red) are 0.47, 0.44, and
0.50 substitutions per site, respectively.
A multiple amino acid sequence alignment of the B. cereus group
BC3987 homologs, NrdH-redoxins, and Cp9 homologs included
in the phylogenetic analysis shows that several residues are highly
conserved for all classes in addition to the cysteines in the C-x-x-C
motif (Figure S1). Using the amino acid numbering from BC3987
the Pro54, Gly65, and Phe66 are conserved for all the sequences
included in the alignment. In addition, a N-terminal [IV]-X-
[ILV]-[YF]-[ST] motif ranging from residue 4 to 8 and a [LI]
residue at position 71 seems to be conserved within all classes. The
active site motif (Figure 2, right side) has a larger variation in the
Cp9 homologous proteins (C-[PGI]-[PYWQ]-C) than the NrdH-
redoxins (C-[VMI]-Q-C), however, the Grx-like C-P-[YW]-C
motif seems to be the most common within the Cp9 group.
BC3987 and Cp9 homologous sequences have an insert at position
44 that is a Leu or Met residue that is not present in the NrdH
proteins (Figure S1). The other B. cereus group BC3987 homologs
also have this insert, supporting the co-classification with Cp9.
From these results we suggest that the Bacillus genus BC3987
homologs, Cp9 homologs, and NrdH-redoxins form three
evolutionary separated groups.
However, due to the occurrence of the same amino acid
insertion and the higher sequence identity observed for the Bacillus
genus BC3987 homolog group and the Cp9 homologs one might
expect a closer structural, and perhaps functional, relationship for
these two groups compared to the NrdH-redoxins.
Identification of Conserved Amino Acids Preceding the
C-x-x-C Site in Thioredoxin-like Proteins
In general the local environment of the active site cysteines is
considered to be very important with regard to reactivity and
redox potential of Trx. Within the 6 amino acids preceding the C-
x-x-C motif there are often highly conserved Asp, Thr, and Ser
residues that have been shown to affect the activity of the enzyme
or are suggested to do so. These residues are located on a b-strand
that folds back on the active site, thus the amino acid side chains in
position 2, 4, and 6 can point towards the buried cysteine. All
proteins in the IMG database having less than 160 amino acids
and containing either x(6)-C-G-P-C (Trxs), x(6)-C-P-[FYW]-C
(Grxs), x(6)-C-[VIM]-Q-C (NrdH-redoxins), or x(6)-C-P-P-C
motifs (PROSITE syntax used to describe motifs) and being
annotated as either Trxs, Grxs, or NrdH-redoxins, have been
analyzed with focus on the [DE]-x-[ST]-x(3) motif preceding the
active site (Table 1).
Quality of the BC3987 Crystal Structure
The BC3987 wild type and T8A mutant structures were refined
to 1.4 and 1.18 A˚, respectively. In the wild type structure residues
1–76 and 3–75 are observed in chain A and B, respectively. Chain
A shows the overall highest quality with residues 1–76 visible in the
electron density map, while residues Lys35, Lys36, Phe66, Glu69,
and Gln72 in chain B lack density at a few side chain atoms. In the
T8A mutant structure, all residues 1–78 are visible in the electron
density map of the corresponding high quality chain. In the other
chain, residues 3–76 are observed, with lacking density at the side
chain atoms of Asn76. Refinement and validation statistics are
presented in Table 2.
Overall Structure of BC3987
Like E. coli and C. ammoniagenes NrdH the BC3987 have a a/b/a
Trx fold typical for all members of the Thioredoxin superfamily.
The structure has a Ca RMSD value of 1.26 A˚ with the E. coli
Figure 2. Insulin reduction by wild type and mutant BC3987. In
the insulin reduction assay, the rate of insulin disulfide reduction by
DTT is enhanced using 10 mM thioredoxin as a catalyst. The wild type
BX3987 thioredoxin (&) is more efficient than the T8A mutant (N). The
control experiment without thioredoxin shows that the uncatalyzed
reaction with DTT is very slow (m). The concentration of insulin and DTT
used in the assay was 160 mM and 1 mM, respectively. The turbidity of
the assay solution was monitored at 580 nm (light scattering).
doi:10.1371/journal.pone.0069411.g002
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NrdH (PDBid:1H75). Due to the insert of one Leu amino acid at
position 44 in the BC3987 protein, the a2 helix is positioned
slightly closer to the b-sheet layer compared to E. coli NrdH. The
amino acid insert not found in NrdH-redoxins (Leu44) points into
the cavity on the BC3987 surface that resembles the binding site
for TrxR described by Lennon et al. [63].
Figure 3. Phylogenetic analysis of thioredoxins similar to BC3987. Bootstrap values obtained at a 50% consensus level using the Maximum
Likelihood algorithm with 1000 replicates are shown at the branches of the tree. The evolutionary distances from the node separating the three
clusters BC3987 homologs (in blue), Cp9 homologs (in green), and NrdH-redoxins (in red) are 0.47, 0.44, and 0.50 substitutions per site, respectively.
Among the BC3987 homologs the active sites always have the -C-P-P-C- motif while the classical glutaredoxin active site motif -C-P-[YW]-C- is
prevalent for the Cp9-like proteins. For the NrdH-redoxins, all encoded in a nrdHIEF operon, the predominant active site motif is -C-V-Q-C-. Alignment
shown in Figure S1 (same color coding).
doi:10.1371/journal.pone.0069411.g003
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The C-P-P-C Active Site Motif
The BC3987 protein has a C-P-P-C active site motif that differs
from what is typically observed for Trxs and Grxs. Additionally,
the residues Thr8 and Thr53 in the vicinity of the disulfide bridge
are possible hydrogen bond partners for the buried C-terminal
cysteine (Figure 4A). Contrary to what is seen in the NrdH-
redoxins from E. coli and C. ammoniagenes crystal structures the
Thr8 residue in BC3987 has a rotamer where the hydroxyl group
is pointing away from the buried Cys15 Sc-atom. This orientation
of Thr8 is stabilized by a hydrogen bond to a water molecule
(HOH34). The proline residues apply restrictions on the protein
backbone, making a rigid frame for the active site cysteines. Both
proline residues in the BC3987 active site have the trans-
conformation with v-angles of 177u and 176u for the Pro13 and
Pro14, respectively. These values fall within the v-angle standard
deviation observed for trans-proline residues with the UP-pucker
Table 1. Categorization of active site motifs in thioredoxin-like proteins (% of sequences)a.
x-x amino acids
Active site motifb Thioredoxin Glutaredoxin NrdH Other
G-P P-[FYW] [VIM]-Q P-P
x(6)-C-x-x-C 61.1 25.2 8.5 5.2
x(2)-[ST]-x(3)-C-x-x-C 3.0 15.1 8.5 2.7 (2.2 T, 0.5 S)
[DE]-x(5)-C-x-x-C 56.5 0 0 1.3
[DE]x[ST]-x(3)-C-x-x-C 1.5 0 0 0.3
aAnalysis of 2627 sequences. All sequences between 60 and 160 amino acids in the Integrated Microbial Genomes database (http://img.jgi.doe.gov) containing a x(6)-C-
x-x-C motif were downloaded. Sequences that were not annotated or did not have a Pfam classification as a member of the thioredoxin superfamily were deleted prior
to the analysis.
bPROSITE syntax (http://au.expasy.org/tools/scanprosite/scanprosite-doc.html#pattern_syntax) is used to describe the amino acid motifs preceeding the N-terminal
active site Cys.
doi:10.1371/journal.pone.0069411.t001
Table 2. Crystal data, data collection, and refinement statistics.
Crystal data
Wild type T8A mutant
Space group P21
Crystal parameters a = 24.7, b = 98.9, c = 25.1 a = 24.4, b = 99.1, c = 25.2
a=90, b= 91.8, c= 90 a= 90, b= 91.6, c= 90
Data collection
X-ray source ESRF, ID29 ESRF, ID29
Resolution (A˚)a 33–1.4 (1.48–1.4) 24.8–1.18 (1.25–1.18)
Wavelength (A˚) 0.975948 0.976273
Temperature (K) 100 100
Completeness (%)a 94.3 (93.8) 84.9 (83.1)
Redundancy (%)a 2.6 (2.6) 3.1 (3.0)
I/s(I)a 15.0 (6.1) 13.1 (4.9)
Rsym (%)
b 0.03 (0.11) 0.04 (0.18)
Refinement statistics
Rcryst (%)
c 18.8 14.4
Rfree (%)
d 20.5 19.7
Mean overall isotropic B-factor (A˚2) 19.9 20.8
Ramachandran plot: ration in most favored/other allowed
regions (%)
RMS deviation from standard bond lengths (A˚)/angles (u) 0.026/2.44 0.026/2.40
Added waters 98 88
PDB code 3ZIJ 3ZIT
aValues for outer shell in parenthesis.
bRsym =S|I–ÆIæ|/SI.
cRcryst =S(|Fobs|–|Fcalc|)/S|Fobs.|.
dRfree is the Rcryst value calculated on the 5% reflections excluded for refinement.
doi:10.1371/journal.pone.0069411.t002
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[64], indicating that the motif probably is structurally relaxed. The
crystal structure of the T8A mutant resembles the wild type
structure and the C-P-P-C motifs in these structures superimpose
with a RMSD value of 0.053 (Figure 4B). A superimposition of the
oxidized C-P-P-C motif in BC3987 and the corresponding
reduced C-P-P-C motifs found in Tryparedoxin-II (TXN-II) from
Crithidia fasciculate (PDBid:1FG4) and Poplar Trx h1(PDBid:1TI3,
model 3) is shown in Figure 4C. The RMS values calculated for all
C-P-P-C atoms except Cys-Cb/Sc are 0.32 and 0.22 A˚ with
Tryparedoxin II and Trx h1, respectively, indicating that the
disulfide redox state does not influence the active site conforma-
tion notably.
QM/MM Modeling of the Reduced Active Site Motif
Based on the results from the Cys pKa titration experiments and
the different Thr rotamers observed in the crystal structures of
BC3987 and the NrdH-redoxins one might speculate that the
conserved Thr8 could contribute to lower the buried cysteine pKa
value through hydrogen bonding. In the structure it is apparent
that the Gln9 amide proton is within hydrogen bonding distance
to the Sc-atom of Cys15, however, a Thr8 with a rotamer as
observed in E. coli and C. ammoniagenes NrdH-redoxins could also
act as a hydrogen bond donor to this atom. Additonally, it was of
interest to examine if the variable Thr53 could form a hydrogen
bond to the buried cysteine thiolate when BC3987 was in the
reduced form.
To be able to investigate the effects of Thr8 and Thr53, a QM/
MM modeling approach including the whole protein was chosen.
The largest part of the protein (the low layer, cartoon represen-
tation in Figure 5A) was modeled by a classical force field, while
hybrid density functional theory was used to describe the active
site and its immediate surroundings (the high layer, ball-and-stick
representation in Figure 5A). Geometrical restraints were applied
on the active site to mimic the limited conformational difference
between red-ox states observed in Tryparedoxin-II and Poplar Trx
h1 (Figure 4C). From the two models of the reduced active site,
Model I with Thr8 having the rotamer observed in the BC3987
crystal structure (Figure 5B) and Model II where the conformation
of Thr8 resemble the corresponding Thr residue in NrdH-
redoxins (Figure 5C), there are several differences. Hydrogen
bonding distances within the active site in Model I and II have
been summarized in Table 3. Additionally, the pKa values of the
cysteines in both geometry optimized structures were estimated
using the program PROPKA 2.0 [17], and the perturbations
caused by the individual hydrogen bonds are also shown in
Table 3.
In both models the nucleophilic Cys12 side chain is hydrogen
bonded to the Cys15 amide proton, rationalizing the perturbed
pKa value of this thiol. It is also clear that the amide protein of
Gln9 can form a hydrogen bond to the buried Cys15 thiolate in
both Model I and II. A limited perturbation of the variable Thr53
residue on the Cys12 pKa value is predicted, the effect being
similar in magnitude for both models. Indeed, an additional
hydrogen bond from Thr8 to the buried cysteine thiolate can be
observed in Model II (Figure 5C), resulting in calculated pKa
Figure 4. Structure of BC3987 active site. (A) The active site and
immediate surroundings in BC3987. Thr8 and Thr53 can possibly form
hydrogen bonds to the Sc-atom of Cys15 upon reduction of the
disulfide bridge. The |2Fo–Fc| map is contoured at 1.5 s. (B) The wild
type (in brown) and T8A (in blue) crystal structures have CPPC active
sites that superimpose with a RMS value of 0.053 A˚. This verifies that
the mutation does not disturb the CPPC active site. (C) Comparison of
C-P-P-C motifs in oxidized BC3987 (in brown), reduced Tryparedoxin,
TXN-II, (in green), and reduced Trx h1 (in grey). From this superimpo-
sition, it is suggested that the cysteine side chains and not the
backbone undergo the largest structural rearrangement upon reduc-
tion of the active site.
doi:10.1371/journal.pone.0069411.g004
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values of 7.1 and 6.5 for Cys12 and Cys15, respectively. The
corresponding values for Model I are 7.1 and 8.0, indicating that
Model II is most compatible with experimental observations and
supporting the hypothesis that Thr8 is involved in the stabilization
of the Cys15 thiolate. With respect to computed energies, the high
layer B3LYP energy is 8.7 kcal/mol lower for Model II compared
to Model I, however, the total ONIOM energy for Model II is
11.8 kcal/mol higher than for Model I. This indicates that effects
from the protein low layer disfavor Model II compared to Model I,
while the active site electronic structure in Model II is stabilized by
the hydrogen bond between Thr8 and Cys15.
Discussion
The thioredoxin BC3987 found in B. cereus ATCC 14579 is
conserved among all the members of the B. cereus group, including
Figure 5. QM/MM models of the BC3987 active site. (A) QM/MM geometry optimized structure of BC3987 showing the quantum mechanical
and molecular mechanics regions in ball-and-stick and cartoon representation, respectively. (B) Active site (Model I) where the Thr8 residue has the
rotamer observed in the crystal structure. The Cys12 side chain is hydrogen bonded to the Cys15 amide proton. The Gln9 amide proton is a possible
hydrogen bond donor to the buried Cys15 thiolate. (C) In this structure (Model II) the Thr8 side chain was rotated to resemble the rotamer observed
in E. coli and C. ammoniagenes NrdH-redoxins prior to geometry optimization. The Thr8 hydroxyl group and Gln9 amide proton appear to form
hydrogen bonds to the buried Cys15 side chain while the Cys12 side chain is hydrogen bonded to the Cys15 amide proton. The link atoms
connecting the MM and QM layer in B and C are colored pink.
doi:10.1371/journal.pone.0069411.g005
Table 3. Hydrogen bond distancesa to active site thiolates and their estimated perturbation DpKa
b on the pKa values.
Donor atom Thr53-Oc Thr8- Oc Gln9-Namide Cys15-Namide Estimated pKa
Model I Cys12 4.38 A˚ – – 3.70 A˚ 7.1
20.19b – – 21.74b
Cys15 4.20 A˚ – 3.68 A˚ – 8.0
20.49b – 21.07b –
Model II Cys12 4.41 A˚ – 5.26 A˚ 3.80 A˚ 7.1
20.14b – 20.08b 21.70b
Cys15 – 3.09 A˚ 3.71 A˚ – 6.4
– 21.60b 21.66b –
Experiment Cys12 7.2
Cys15 5.1
aHydrogen bonding distances obtained from the geometry optimized structures Model I and Model II.
bThe perturbation of the thiolate pKa values due to hydrogen bonding were calculated using the program PROPKA 2.0 (http://propka.ki.ku.dk/).
doi:10.1371/journal.pone.0069411.t003
How Hydrogen Bonds Can Modify Thiol pKa Values
PLOS ONE | www.plosone.org 8 July 2013 | Volume 8 | Issue 7 | e69411
B. anthracis, B. mycoides, B. pseudomycoides, B. thuringiensis and B.
weihenstephanensis. It has been shown that BC3987 can function as
an electron donor to class Ib RNR [30]. However, subsequent
studies using the corresponding enzymes from B. anthracis showed
that the BC3987 homolog is 6–7 times less effective than Trx1 in
reducing RNR and that Trx1 is 60 fold abundant compared to the
BC3987 homolog [31]. Thus, it is most likely that Trx1 is the
in vivo electron donor to class Ib RNR in both B. anthracis and B.
cereus.
The protein showing the highest amino acid identity (37%) to
BC3987 does not belong to a member of the Bacillus genus, but is a
small Trx (NT01CX_2375) found in the anaerobe C. novyi. This
protein has 58% sequence identity with the C. pasteurianum
thioredoxin Cp9 that is encoded in an operon between a NADH
dependent TrxR and a Prx (Figure 6A), functioning as an electron
transporter between these two proteins [29]. The NT01CX_2375
gene is found in an identical operon structure as Cp9 with flanking
TrxR and Prx. These three proteins have been found to be present
at relatively high levels in C. novyi spores [65]. B. cereus ATCC
14579 has a gene (BC2114) encoding a protein that has 54%
sequence identity to the C. novyi Prx, however, this gene is not
colocated with any TrxR or Trx genes. Thus, one possible
substrate for BC3987 is the putative Prx BC2114. Aside, it should
be mentioned that several non-bacterial Prxs with,50% sequence
identity to BC2114 have been characterized, and that some of
them are reduced by redoxins with C-P-P-C active site motifs as
found in BC3987 [66,67].
In order to relate BC3987 to the Cp9-redoxins found in C.
pasteurianum/novyi and NrdH-redoxins, a phylogenetic analysis of a
collection of sequences representing these proteins were carried
out. The tree shown in Figure 2 indicates that the BC3987
homologs found among the members in the Bacillus cereus group
form a separate cluster from the NrdH-redoxins and the proteins
homologues to the C. pasteurianum/novyi Cp9 thioredoxin. A
slightly shorter evolutionary distance is observed between the
clusters represented by BC3987 and the C. pasteurianum/novyi Cp9
compared to that formed by NrdH-redoxins. The amino acid
deletion at position 44 in the NrdH-redoxins was not taken into
account while performing the phylogenetic analysis, thus, this
deletion increase the evolutionary distance of the NrdH-redoxins
to the other two groups further. The role of BC3987 as a part of
Prx-mediated defense against reactive oxygen species in B. cereus is
currently investigated in our laboratory.
The only two cysteine residues in the protein are found in the
active site, and the observation that the change in the molar
extinction coefficient De240 nm was about twice of the expected
value for one thiol/thiolate pair indicate that both active site
cysteines have lowered pKa values. Similar observations have been
made for the B. subtilis thiol-disulfide oxidoreductases ResA and
StoA where a water molecule bound to a Glu residue can
hydrogen bond to the C-terminal buried cysteine and lower its
pKa value [68,69]. The mechanism for lowered thiol pKa values in
C-x-x-C active sites involved in redox chemistry is discussed
below.
In Figure 3 it is shown that the C-x-x-C motifs among
established and putative Trxs have substantial variation. The
typical Trx active site motif is C-G-P-C as seen in Table 1 where a
large number of thioredoxin superfamily members have been
analyzed and compared, also including the six amino acids
preceding the C-x-x-C motif.
About 92% of the typical Trxs included in the survey have an
acidic Asp or Glu residue in the sixth position preceding the C-G-
P-C motif, and it has been proposed that this residue acts as a
general acid/base catalyst for proton transfer during reduction and
oxidation of the disulfide bridge [22]. For E. coli Trx, this residue,
which is located 5.6 A˚ away from the buried C-terminal active site
cysteine, has been demonstrated to be essential for catalytic
efficiency [21]. It has also been suggested that a Ser or Thr residue
four residues in front of the C-x-x-C motif, [ST]-x(3)-C-x(2)-C,
influence Trx activity by interacting directly with the previously
discussed Asp residue [70] or the buried Cys residue [71]. Yet, less
than 5% of the C-G-P-C type Trxs included in our survey has a
Ser or Thr residue in this position (Table 1), indicating that such
an arrangement is not a general feature for this type of Trxs. None
of the Grxs or NrdH-redoxins have an Asp or Glu in the sixth
position. However, the [ST]-x(3)-C-x(2)-C motif is observed in 60
and 99.5% of Grxs and NrdH-redoxins (Table 1), respectively. As
we have shown in this work, mutation of the Thr8 residue in the
forth position preceding the C-P-P-C motif decrease the catalytic
efficiency of the enzyme (Figure 2).
In the structures of the oxidized NrdH-redoxins from E. coli and
C. ammoniagenes the hydroxyl O- atom of the Thr residue in T-x(3)-
C-V-Q-C motif is oriented towards the buried Cys-Sc with
distances of 3.4 and 3.8 A˚, both being potential hydrogen bonding
partners with the cysteine thiol/thiolate when the active sites are in
their reduced states.
In BC3987, which has a 6V-Y-T-Q-P-D-C-P-P-C15 motif, Thr8
is a potential hydrogen bond donor to Cys15-Sc. However, in the
BC3987 crystal structure the side chain of this residue is hydrogen
bonded to a water molecule resulting in a rotamer where the Thr
hydroxyl group points away from the buried Cys15 as shown in
Figure 3A, different from what observed in the E. coli and C.
ammoniagenes NrdH-redoxins. Considering the similarity of the
Thr8 environment with those of Thr7 in the E. coli and C.
ammoniagenes NrdH-redoxins, a low energy barrier between the two
rotamers seems likely. In addition, the Thr53 residue, not
conserved within the NrdH and Cp9-redoxin families, was found
in the vicinity of the active site. Thus, there are two potential
Figure 6. Overview of operon organization of Cp9-redoxins,
NrdH-redoxins, and BC3987. (A) The gene encoding the Cp9-
redoxin is located between a thioredoxin reductase (cp34) and a
peroxiredoxin (cp20). (B) The classical class Ib RNR operon where the
NrdH-redoxin is found in front of the genes encoding the flavodoxin-
like protein NrdI, the catalytic subunit NrdE and the radical/metal
cofactor containing NrdF protein. (C) The organization of class Ib RNR
genes in the Bacillus cereus group where the putative NrdH-redoxin
(BC3987) is located elsewhere in the genome.
doi:10.1371/journal.pone.0069411.g006
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hydrogen bond donors to the Cys15 Sc-atom in addition to the
Gln9 amide protein.
The modeling studies of the reduced active site provided
information on its possible hydrogen bond arrangements. Two
models were examined using QM/MM calculations, one where
Thr8 had the rotamer present in the BC3987 crystal structure
(Model I, Figure 5B) and one where the Thr8 side chain had been
rotated to resemble the conformation found in E. coli and C.
ammoniagenes NrdH-redoxins (Model II, Figure 5C). The experi-
mentally observed lowered pKa values for the buried cysteine
thiol, can be explained through hydrogen bonding from the Gln9
amide protein and the Thr8 side chain. Showing that the E. coli
and C. ammoniagenes NrdH-redoxin Thr8 rotamer is capable to
form a hydrogen bond to the buried cysteine has important
implications for all Trxs having the [ST]-x(3)-C-x-x-C motif. Such
an interaction can result in a stabilization of the buried cysteine
thiolate in the active site at physiological pH values, making a
simple reaction mechanism like the one presented in Figure 7
plausible. In this mechanism, the initial nucleophilic attack is
carried out by the solvent exposed Cys12 that is stabilized in its
deprotonated thiolate form due to hydrogen bonding to the Cys15
amide protein (Figure 7A). This primary activation of the
nucleophilic cysteine could be general to all Trxs. To break the
resulting mixed disulfide intermediate the buried Cys15 needs to
be deprotonated to perform the second nucleophilic attack. We
suggest that Cys15 is already in its deprotonated form, stabilized
by hydrogen bonding to Thr8 and Gln9 (Figure 7B). Thus, this
mechanism offers an elegant explanation of the deprotonation of
the buried cysteine in Trxs that lack an analog to the Asp26
residue in E. coli Trx.
In summary it has been shown that BC3987 appears to be a
closer relative to Trxs that reduce peroxiredoxins than NrdH-
redoxins that provide electrons to the catalytic subunit of class Ib
ribonucleotide reductases. The observation that the reduced form
of BC3987 seems to possess two cysteine residues in the active site
with lowered pKa values have been explained through intra-
protein hydrogen bonding patterns. Disturbing the hydrogen
bonding networks by removing a highly conserved Thr residue
near the buried Cys resulted in decreased efficiency for the
BC3987 thioredoxin.
Supporting Information
Figure S1 Multiple alignment of amino acid sequences of
NrdH-redoxins (in red), Cp9/NT01CX_2375 homologs (in
green), and BC3987 homologs (in blue). The columns containing
the conserved Thr/Ser residues in position 8, and the gaps in the
NrdH-redoxin sequences in position 44, are marked with arrows
and with orange background.
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Figure S1. Multiple alignment of amino acid sequences of NrdH-redoxins (in red), Cp9/ 
NT01CX_2375 homologs (in green), and BC3987 homologs (in blue). The columns 
containing the conserved Thr/ Ser residues in position 8, and the gaps in the NrdH-redoxin 
sequences in position 44, are marked with arrows and with orange background.   
The corresponding species and accession numbers of the sequence names are as follows: 
CA_NRDH; Corynebacterium ammoniagenes (O69271), MC_NRDH; Mycobacterium 
tuberculosis (NP_217569), NF_NRDH; Nocardia farcinica (YP_120522), CJ_NRDH; 
Corynebacterium jeikeium (YP_250251), BRS_NRDH; Brucella abortus (YP_001932759), 
RL_NRDH; Rhizobium leguminosarum (YP_769836), PD_NRDH; Paracoccus denitrificans 
(YP_001607868), VS_NRDH; Vibrio sp. (ZP_01066345), YP_NRDH; Yersinia pestis 
(YP_001873486), EC_NRDH; Escherichia coli (ZP_03083809), ST_NRDH; Salmonella 
enteric (YP_002115761), SP_NRDH; Streptococcus pyogenes (NP_269480), STP_NRDH; 
Streptococcus pneumonia (YP_002037786), LL_NRDH; Lactococcus lactis 
(YP_001032827), EF_NRDH; Enterococcus faecalis (NP_814257), RX_YRUB; Rubrobacter 
xylanophilus (YP_644383), CPER_YRUB; Clostridium perfringens (ZP_02953769), 
CB_YRUB; Clostridium beijerinckii (YP_001307271), CN_YRUB(NT01CX_2375); 
Clostridium novyi (YP_878448), CPAS_YRUB; Clostridium pasteurianum (P23171), 
CT_YRUB; Clostridium thermocellum (YP_001036667), TP_YRUB; Thermotoga petrophila 
(YP_001245300), FN_YRUB; Fervidobacterium nodosum (YP_001410364), TM_YRUB; 
Thermosipho melanesiensis (YP_001305804), PM_YRUB; Petrotoga mobilis 
(YP_001568453), BSP_YRUB; Bacillus sp. (ZP_01860678), BW_YRUB; Bacillus 
weihenstephanensis (YP_001646612), BC3987; Bacillus cereus (NP_833706), BAA_NRDH; 
Bacillus anthracis (YP_030147), BC_YRUB; Bacillus cereus subsp. Cytotoxis 
(YP_001375918), SA_YRUB; Staphylococcus aureus (YP_185957). 
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